21,846 results on '"PULMONARY function tests"'
Search Results
2. Does Regular Exercise Impact the Lung Function of Healthy Children and Adolescents? A Systematic Review and Meta-Analysis.
- Author
-
Balbinot, Fernanda, Claudino, Felipe César de Almeida, Lucas, Pedro Kazlauckas, Martins, Ana Paula Donadello, Wendland, Eliana M., and Gerbase, Margaret W.
- Subjects
LUNG physiology ,META-analysis ,CONFIDENCE intervals ,SYSTEMATIC reviews ,EXERCISE physiology ,PUBLIC health ,VITAL capacity (Respiration) ,PHYSICAL activity ,EXERCISE ,RESPIRATORY organ physiology ,PULMONARY function tests ,FORCED expiratory volume ,DESCRIPTIVE statistics ,SPIROMETRY ,EXPIRATORY flow ,DATA analysis software ,CHILDREN - Abstract
Purpose: To assess the quality of the available evidence on the effect of exercise for the improvement of lung function in healthy children and adolescents. Method: We performed a systematic review and meta-analysis of intervention studies examining the effects of regular exercise on spirometric parameters of healthy children and adolescents aged ≤18 years. Results: Within the exercise groups, there were significant improvements in forced vital capacity (mean difference: 0.17 L; 95% confidence interval, 0.07 to 0.26; P <.05) and forced expiratory volume in the first second (mean difference: 0.14 L; 95% confidence interval, 0.06 to 0.22; P <.05). Results were consistent across different age groups and duration of interventions. In the between-group analysis, forced vital capacity, forced expiratory volume in the first second, and peak expiratory flow were higher in the exercise group compared with the nonexercise group, but the differences did not reach statistical relevance. There was significant statistical heterogeneity between studies. Conclusion: Regular exercise has the potential to improve lung function parameters in healthy children and adolescents; however, the small number of studies and the heterogeneity between them raise concern about the quality of the currently available evidence. These findings bring to attention the need for well-designed trials addressing this important public health issue. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Automated asthma detection in a 1326-subject cohort using a one-dimensional attractive-and-repulsive center-symmetric local binary pattern technique with cough sounds.
- Author
-
Barua, Prabal Datta, Keles, Tugce, Kuluozturk, Mutlu, Kobat, Mehmet Ali, Dogan, Sengul, Baygin, Mehmet, Tuncer, Turker, Tan, Ru-San, and Acharya, U. Rajendra
- Subjects
- *
MACHINE learning , *PULMONARY function tests , *SUPPORT vector machines , *BIOMEDICAL engineering , *COUGH - Abstract
Asthma is a common disease. The clinical diagnosis is usually confirmed on a pulmonary function test, which is not always readily accessible. We aimed to develop a computationally lightweight handcrafted machine learning model for asthma detection based on cough sounds recorded using mobile phones. Toward this aim, we proposed a novel feature extractor based on a one-dimensional version of the published attractive-and-repulsive center-symmetric local binary pattern (1D-ARCSLBP), which we tested on a new cough sound dataset. We prospectively recorded cough sounds from 511 asthmatics and 815 non-asthmatic subjects (comprising mostly healthy volunteers), which yielded 1875 one-second cough sound segments for analysis. Our model comprised four steps: (i) preprocessing, in which speech signals and stop times (silent zones between coughs) were removed, leaving behind analyzable cough sound segments; (ii) feature extraction, in which tunable q-factor wavelet transformation was used to perform multilevel signal decomposition into wavelet subbands, allowing 1D-ARCSLBP to extract local low- and high-level features; (iii) feature selection, in which neighborhood component analysis was used to select the most discriminative features; and (iv) classification, in which a standard shallow cubic support vector machine was deployed to calculate binary classification results (asthma versus non-asthma) using tenfold and leave-one-subject-out cross-validations. Our model attained 98.24% and 96.91% accuracy rates with tenfold and leave-one-subject-out cross-validation strategies, respectively, and obtained a low-time complexity. The excellent results confirmed the feature extraction capability of 1D-ARCSLBP and the feasibility of the model being developed into a real-world application for asthma screening. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis–associated interstitial lung disease: a survey of rheumatologists.
- Author
-
Park, Elizabeth, Iqbal, Rabia, Giles, Jon T., and Bernstein, Elana J.
- Subjects
- *
TUMOR necrosis factors , *HYPERSENSITIVITY pneumonitis , *PULMONARY function tests , *ANTIRHEUMATIC agents , *MEDICAL screening - Abstract
This document is a letter published in the journal Clinical Rheumatology. It discusses the use of methotrexate (MTX) and tumor necrosis factor inhibitors (TNFi) in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). The letter presents the results of a survey conducted among rheumatologists regarding their practices and opinions on the use of these medications in RA-ILD. The survey found that many rheumatologists would perform pulmonary screening prior to initiating MTX or TNFi, but most would not repeat screening. The majority of respondents would avoid MTX in patients with a documented history of ILD or hypersensitivity pneumonitis (HP). The letter also mentions the release of new guidelines by the American College of Rheumatology (ACR) for the management of systemic autoimmune rheumatic disease-associated ILD, which may impact clinical practice. The authors acknowledge the limitations of the survey and suggest further exploration of these practice trends in light of the new guidelines. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
5. Long-Term Consequences of Spirometry During Military Routine Medical Examinations on Smoking Cessation Compared to Minimal Advice.
- Author
-
Perisse, Anne, Dao, Marie-Cécile, Butty, Damien, Derkenne, Clement, Charton, France, Fabre, Nathalie, Grosset-Janin, Anais, Lutringer, Manon, Chanet, Aurore, Diop, Elie, Attia, Claire, Coudert, Anne, Courson, Audrey, Maillot, Gaelle, Augen, Anne-Sophie, Bagary, Pierre, Sahuguet, Emilie, Remond, Odile, Paleiron, Nicolas, and Bylicki, Olivier
- Subjects
- *
PULMONARY function tests , *MEDICAL function tests , *SMOKING cessation , *TOBACCO use , *PERIODIC health examinations - Abstract
Background Smoking kills 8 million people a year worldwide. It is the most prevalent cause of death in France by cancer, cardiovascular, or respiratory diseases. Minimal advice consists in asking patients who smoke if they are interested in quitting. It is effective in reducing smoking. The French High Health Authority recommends its systematic use with patients, whatever their reason for seeking treatment. The beneficial effect of spirometry on smoking cessation is controversial. The objective of our study was to measure the consequences of spirometry associated with minimal advice, compared with only minimal advice in soldiers seen during a routine medical examination. Methods Our prospective, longitudinal, open, multicenter, controlled, randomized study was conducted among French military smokers presenting for an occupational medicine visit. Each participant received, depending on their group (intervention or control), either minimal advice associated with an evaluation of lung function by mini-spirometer, or only minimal advice. Follow-up visits were performed at 6 and 12 months. The primary objective was self-reported tobacco use cessation at 6 months. Results A total of 267 participants (126 in the intervention group and 141 for the control arm) were included in 10 centers between June 2019 and June 2020. The response rate was 75.6% at 6 months. The cessation rates were 17% and 18% in the intervention and control groups, respectively, with no significant difference between the two groups (P = 0.9). The cessation rate in the general population was 13% at 6 months. Conclusions Spirometry does not seem to influence smoke cessation on a military population at 6 months. The overall cessation rate in our study was well in excess of the 3-6% expected from only providing minimal which is underused in general practice and should be encouraged. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.
- Author
-
Keller, Michael B., Newman, David, Alnababteh, Muhtadi, Ponor, Lucia, Shah, Pali, Mathew, Joby, Kong, Hyesik, Andargie, Temesgen, Park, Woojin, Charya, Ananth, Luikart, Helen, Aryal, Shambhu, Nathan, Steven D., Orens, Jonathan B., Khush, Kiran K., Jang, Moon, and Agbor-Enoh, Sean
- Subjects
- *
CELL-free DNA , *LUNG transplantation , *SHOTGUN sequencing , *PULMONARY function tests , *SYMPTOMS - Abstract
Lung transplant recipients are traditionally monitored with pulmonary function testing (PFT) and lung biopsy to detect post-transplant complications and guide treatment. Plasma donor-derived cell free DNA (dd-cfDNA) is a novel molecular approach of assessing allograft injury, including subclinical allograft dysfunction. The aim of this study was to determine if episodes of extreme molecular injury (EMI) in lung transplant recipients increases the risk of chronic lung allograft dysfunction (CLAD) or death. This multicenter prospective cohort study included 238 lung transplant recipients. Serial plasma samples were collected for dd-cfDNA measurement by shotgun sequencing. EMI was defined as a dd-cfDNA above the third quartile of levels observed for acute rejection (dd-cfDNA level of ≥5% occurring after 45 days post-transplant). EMI was categorized as Secondary if associated with co-existing acute rejection, infection or PFT decline; or Primary if not associated with these conditions. EMI developed in 16% of patients at a median 343.5 (IQR: 177.3–535.5) days post-transplant. Over 50% of EMI episodes were classified as Primary. EMI was associated with an increased risk of severe CLAD or death (HR: 2.78, 95% CI: 1.26–6.22, p = 0.012). The risk remained consistent for the Primary EMI subgroup (HR: 2.34, 95% CI 1.18–4.85, p = 0.015). Time to first EMI episode was a significant predictor of the likelihood of developing CLAD or death (AUC = 0.856, 95% CI = 0.805–0.908, p < 0.001). Episodes of EMI in lung transplant recipients are often isolated and may not be detectable with traditional clinical monitoring approaches. EMI is associated with an increased risk of severe CLAD or death, independent of concomitant transplant complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Quantifying Regional Radiation-Induced Lung Injury in Patients Using Hyperpolarized 129Xe Gas Exchange Magnetic Resonance Imaging.
- Author
-
Rankine, Leith J., Lu, Junlan, Wang, Ziyi, Kelsey, Christopher R., Marks, Lawrence B., Das, Shiva K., and Driehuys, Bastiaan
- Subjects
- *
PULMONARY gas exchange , *MAGNETIC resonance imaging , *VITAL capacity (Respiration) , *PEARSON correlation (Statistics) , *PULMONARY function tests - Abstract
Radiation-induced lung injury has been shown to alter regional ventilation and perfusion in the lung. However, changes in regional pulmonary gas exchange have not previously been measured. Ten patients receiving conventional radiation therapy (RT) for lung cancer underwent pre-RT and 3-month post-RT magnetic resonance imaging (MRI) using an established hyperpolarized 129Xe gas exchange technique to map lung function. Four patients underwent an additional 8-month post-RT MRI. The MR signal from inhaled xenon was measured in the following 3 pulmonary compartments: the lung airspaces, the alveolar membrane tissue, and the pulmonary capillaries (interacting with red blood cells [RBCs]). Thoracic 1H MRI scans were acquired, and deformable registration was used to transfer 129Xe functional maps to the RT planning computed tomography scan. The RT-associated changes in ventilation, membrane uptake, and RBC transfer were computed as a function of regional lung dose (equivalent dose in 2-Gy fractions). Pearson correlations and t tests were used to determine statistical significance, and weighted sum of squares linear regression subsequently characterized the dose dependence of each functional component. The pulmonary function testing metrics of forced vital capacity and diffusing capacity for carbon monoxide were also acquired at each time point. Compared with pre-RT baseline, 3-month post-RT ventilation decreased by an average of −0.24 ± 0.05%/Gy (ρ = −0.88; P <.001), membrane uptake increased by 0.69 ± 0.14%/Gy (ρ = 0.94; P <.001), and RBC transfer decreased by −0.41 ± 0.06%/Gy (ρ = −0.92; P <.001). Membrane uptake maintained a strong positive correlation with regional dose at 8 months post-RT, demonstrating an increase of 0.73 ± 0.11%/Gy (ρ = 0.92; P =.006). Changes in membrane uptake and RBC transfer appeared greater in magnitude (%/Gy) for individuals with low heterogeneity in their baseline lung function. An increase in whole-lung membrane uptake showed moderate correlation with decreases in forced vital capacity (ρ = −0.50; P =.17) and diffusing capacity for carbon monoxide (ρ = −0.44; P =.23), with neither correlation reaching statistical significance. Hyperpolarized 129Xe MRI measured and quantified regional, RT-associated, dose-dependent changes in pulmonary gas exchange. This tool could enable future work to improve our understanding and management of radiation-induced lung injury. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Pulmonary function and bronchopulmonary dysplasia classification: insights from the Spanish Registry.
- Author
-
Ramos-Navarro, Cristina, Sánchez-Luna, Manuel, Pérez-Tarazona, Santiago, Sanz-López, Ester, Maderuelo-Rodriguez, Elena, Rueda-Esteban, Santiago, Sánchez-Torres, Ana, Concheiro-Guisán, Ana, Sánchez-Solís, Manuel, Taboada Perianes, María, Gonzalez Torres, Lucía, Sirvent Gómez, Josep, García Cantó, Eva, Moral Gil, Luis, Sáez Sánchez, Ana, Escudero, Carmen, Baquero Cano, Maria, Alfonso Diego, Julia, Mesa Vázquez, Juan, and Coroleu Lletget, Wifredo
- Subjects
- *
PULMONARY function tests , *SCHOOL children , *BRONCHOPULMONARY dysplasia , *PREMATURE infants , *GESTATIONAL age - Abstract
In 2016, the Spanish Research Group on Bronchopulmonary Dysplasia (BPD) (GEIDIS) established a national registry with participation of 66 hospitals to collect information on clinical characteristics and long-term outcomes of BPD infants into adulthood. The aim of this observational study is to examine forced spirometry data in early childhood and to assess their correlation with the respiratory support required at 36 weeks postmenstrual age (PMA). The study analyzed data from preterm infants with BPD born between January 2016 and December 2017 who underwent forced spirometry at 5–7 years of age. Statistical analyses were conducted to investigate the relationships between spirometry results, perinatal factors, and the required respiratory support at 36 weeks PMA. The study involved 143 patients with a median gestational age (GA) of 27.3 weeks (range 25.7–28.7) and a median weight of 880 g (range 740–1135). Abnormal spirometry results were observed in 39.2% (56) of the patients. Among patients diagnosed with BPD type 3, those requiring over 30% oxygen at 36 weeks PMA exhibited an increased risk of abnormal spirometry results (OR 4.48; 95% CI 1.11–18.13) compared to those requiring positive pressure with less than 30% oxygen. In addition, this subgroup had a higher risk of developing a restrictive-mixed pattern compared to those with BPD type 1 (OR 10.65; 95% CI 2.06–54.98) and BPD type 2 (OR 6.76; 95% CI 1.09–42.06). No significant differences were found in the incidence of an obstructive pattern between BPD types. Conclusion: The requirement of more than 30% oxygen at 36 weeks PMA serves as a risk indicator for pulmonary function impairment in school-aged children with BPD. These findings suggest persistent airway and parenchymal injury in this specific patient population, and highlight the importance of careful monitoring to evaluate their long-term effects on lung function. What is Known: • Premature patients with bronchopulmonary dysplasia (BPD) may present abnormalities in pulmonary function tests during school age. However, the predictive accuracy of consensus BPD severity classification remains uncertain. What is New: • The requirement of more than 30% oxygen at 36 weeks postmenstrual age (PMA) indicates a potential risk of pulmonary function impairment in school-aged children with BPD. Additionally, a significant correlation has been observed between a restrictive-mixed pattern with exposure to mechanical ventilation and the development of severe forms of BPD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Adipose-derived stromal vascular fraction cells to treat long-term pulmonary sequelae of coronavirus disease 2019: 12-month follow-up.
- Author
-
Carstens, Michael, Trujillo, Jessy, Dolmus, Yanury, Rivera, Carlos, Calderwood, Santos, Lejarza, Judith, López, Carlos, and Bertram, Kenneth
- Subjects
- *
POST-acute COVID-19 syndrome , *COVID-19 , *CHRONIC cough , *DISEASE complications , *PULMONARY function tests - Abstract
Long coronavirus disease (COVID) is estimated to occur in up to 20% of patients with coronavirus disease 2019 (COVID-19) infections, with many having persistent pulmonary symptoms. Mesenchymal stromal cells (MSCs) have been shown to have powerful immunomodulatory and anti-fibrotic properties. Autologous adipose-derived (AD) stromal vascular fraction (SVF) contains MSC and other healing cell components and can be obtained by small-volume lipoaspiration and administered on the same day. This study was designed to study the safety of AD SVF infused intravenously to treat the pulmonary symptoms of long COVID. Five subjects with persistent cough and dyspnea after hospitalization and subsequent discharge for COVID-19 pneumonia were treated with 40 million intravenous autologous AD SVF cells and followed for 12 months, to include with pulmonary function tests and computed tomography scans of the lung. SVF infusion was safe, with no significant adverse events related to the infusion out to 12 months. Four subjects had improvements in pulmonary symptoms, pulmonary function tests, and computed tomography scans, with some improvement noted as soon as 1 month after SVF treatment. It is not possible to distinguish between naturally occurring improvement or improvement caused by SVF treatment in this small, uncontrolled study. However, the results support further study of autologous AD SVF as a treatment for long COVID. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Shrinking lung syndrome in primary Sjögren's syndrome: a case-based review.
- Author
-
de Oliveira, Jobson Lopes, Cordeiro, Rafael Alves, Guedes, Lissiane Karine Noronha, and Pasoto, Sandra Gofinet
- Subjects
- *
SJOGREN'S syndrome , *SYSTEMIC lupus erythematosus , *CONNECTIVE tissue diseases , *LACRIMAL apparatus , *PULMONARY function tests - Abstract
Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease that affects exocrine glands, mainly the salivary and lacrimal glands, leading to the development of sicca symptoms. Patients with pSS may also present with extraglandular manifestations, including lung involvement, estimated to occur in 9–24% of cases. Shrinking lung syndrome (SLS) is an uncommon respiratory complication primarily associated with systemic lupus erythematosus, with a prevalence of approximately 1% in these patients. It typically manifests as dyspnea, pleuritic chest pain, lung volume reduction, and a restrictive pattern on respiratory function tests. Cases reporting SLS with other connective tissue diseases, including pSS, are even rarer. Herein, we describe a case of a 57-year-old woman with a 10-year history of pSS who presented with dyspnea and pleuritic chest pain. After evaluation, the patient was diagnosed with SLS based on clinical, radiologic, laboratorial, and electrophysiologic characteristics. In addition, we identified and analyzed previously published cases of SLS in pSS. Treatment includes corticosteroids, immunosuppressants, and respiratory muscle training. This study highlights the importance of considering SLS in the differential diagnosis of patients with pSS and respiratory symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Fibroblast activation protein and disease severity, progression, and survival in idiopathic pulmonary fibrosis.
- Author
-
Prior, Thomas Skovhus, Hoyer, Nils, Davidsen, Jesper Rømhild, Shaker, Saher Burhan, Hundahl, Malthe Pallesgaard, Lomholt, Søren, Deleuran, Bent Winding, Bendstrup, Elisabeth, and Kragstrup, Tue Wenzel
- Subjects
- *
IDIOPATHIC pulmonary fibrosis , *INTERSTITIAL lung diseases , *PULMONARY fibrosis , *PULMONARY function tests , *OVERALL survival - Abstract
Idiopathic pulmonary fibrosis (IPF) is characterized by progressive fibrosis in the lungs. Activated fibroblasts play a central role in fibrogenesis and express fibroblast activation protein α. A truncated, soluble form (sFAP) can be measured in blood and is a potential novel biomarker of disease activity. The aim was to study the association between sFAP and clinical, radiological, and histopathological measures of disease severity, progression, and survival in a prospective, multicentre, real‐world cohort of patients with IPF. Patients with IPF were recruited from the tertiary interstitial lung disease centres in Denmark and followed for up to 3 years. Baseline serum levels of sFAP were measured by ELISA in patients with IPF and compared to healthy controls. Pulmonary function tests, 6‐minute walk test and quality of life measures were performed at baseline and during follow‐up. The study included 149 patients with IPF. Median sFAP in IPF was 49.6 ng/mL (IQR: 43.1–61.6 ng/mL) and in healthy controls 73.8 ng/mL (IQR: 62.1–92.0 ng/mL). Continuous sFAP was not associated with disease severity, progression or survival (p > 0.05). After dichotomization of sFAP below or above mean sFAP + 2 SD for healthy controls, higher levels of sFAP were associated with lower FVC % predicted during follow‐up (p < 0.01). Higher than normal serum levels of sFAP were associated with longitudinal changes in FVC % predicted, but sFAP did not show clear associations with other baseline or longitudinal parameters. As such, sFAP has limited use as a biomarker of disease progression or survival in patients with IPF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. A Network Meta-Analysis on the Effects of Different Exercise Types in Patients With COPD.
- Author
-
Chengping Jian, Xiangdong Peng, Yuting Yang, Yanli Xu, Liying Wang, and Defang Cai
- Subjects
EXERCISE physiology ,MEDICAL information storage & retrieval systems ,PULMONARY function tests ,VITAL capacity (Respiration) ,EXERCISE therapy ,HIGH-intensity interval training ,TREATMENT effectiveness ,META-analysis ,DESCRIPTIVE statistics ,SYSTEMATIC reviews ,RESISTANCE training ,MEDLINE ,OBSTRUCTIVE lung diseases ,LUNG diseases ,MEDICAL rehabilitation ,RESPIRATORY organ physiology ,AEROBIC exercises ,MEDICAL databases ,FORCED expiratory volume ,ENDURANCE sports training ,ONLINE information services ,DATA analysis software ,HEALTH outcome assessment ,EVALUATION - Abstract
BACKGROUND: This study aimed to compare and rank the effects of aerobic exercise, resistance training, endurance training, and high-intensity interval training in COPD by network meta-analysis. METHODS: PubMed, Cochrane, Embase, and the Web of Science were searched to identify randomized controlled trials that investigated the effects of exercise training on COPD. The search period began on the date of database establishment and ended on April 8, 2023. Two reviewers independently screened the retrieved articles, extracted relevant data, and assessed the risk of bias in the included studies. Network meta-analysis was performed by using statistical software. RESULTS: This study included a total of 27 studies that involved 1,415 subjects. The network meta-analysis findings indicated that high-intensity interval training was the most-effective intervention for improving 6-min walk distance with a surface under the cumulative ranking curve score of 87.68%. In addition, high-intensity interval training showed the highest efficacy in improving FEV
1 with a surface under the cumulative ranking curve score of 73.17%, FEV1 /FVC with a surface under the cumulative ranking curve score of 79.52%, and St. George Respiratory Questionnaire score with a surface under the cumulative ranking curve score of 73.88%. Conversely, endurance training was found to be the most effective for ameliorating FVC with a surface under the cumulative ranking curve score of 73.39%. CONCLUSIONS: The findings of this study suggest that high-intensity interval training may be more effective than endurance exercise, resistance exercise, and aerobic exercise in improving the 6-min walk distance, FEV1 , FEV1 /FVC, and St. George Respiratory Questionnaire scores in patients with COPD. In addition, endurance training may be better than resistance exercise, aerobic exercise, and high-intensity interval training in improving FVC in patients with COPD. However, due to the limited number of studies conducted on high-intensity interval training, more high-quality randomized controlled trials are required to verify these conclusions. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
13. External validation of the CARDOT score for predicting respiratory complications after thoracic surgery.
- Author
-
Pipanmekaporn, Tanyong, Kitswat, Pakaros, Leurcharusmee, Prangmalee, Runraksar, Thanaporn, Bunchungmongkol, Nutchanart, Khorana, Jiraporn, Tantraworasin, Apichat, Lapisatepun, Panuwat, and Saokaew, Surasak
- Subjects
- *
LUNG disease diagnosis , *PREDICTIVE tests , *PULMONARY function tests , *RECEIVER operating characteristic curves , *THORACIC surgery , *NEUTROPHILS , *RESEARCH methodology evaluation , *LYMPHOCYTES , *RETROSPECTIVE studies , *TERTIARY care , *DESCRIPTIVE statistics , *SURGICAL complications , *MEDICAL records , *ACQUISITION of data , *RESEARCH methodology , *CALIBRATION , *CONFIDENCE intervals - Abstract
Background: The CARDOT scores have been developed for prediction of respiratory complications after thoracic surgery. This study aimed to externally validate the CARDOT score and assess the predictive value of preoperative neutrophil-to-lymphocyte ratio (NLR) for postoperative respiratory complication. Methods: A retrospective cohort study of consecutive thoracic surgical patients at a single tertiary hospital in northern Thailand was conducted. The development and validation datasets were collected between 2006 and 2012 and from 2015 to 2021, respectively. Six prespecified predictive factors were identified, and formed a predictive score, the CARDOT score (chronic obstructive pulmonary disease, American Society of Anesthesiologists physical status, right-sided operation, duration of surgery, preoperative oxygen saturation on room air, thoracotomy), was calculated. The performance of the CARDOT score was evaluated in terms of discrimination by using the area under the receiver operating characteristic (AuROC) curve and calibration. Results: There were 1086 and 1645 patients included in the development and validation datasets. The incidence of respiratory complications was 15.7% (171 of 1086) and 22.5% (370 of 1645) in the development and validation datasets, respectively. The CARDOT score had good discriminative ability for both the development and validation datasets (AuROC 0.789 (95% CI 0.753–0.827) and 0.758 (95% CI 0.730–0.787), respectively). The CARDOT score showed good calibration in both datasets. A high NLR (≥ 4.5) significantly increased the risk of respiratory complications after thoracic surgery (P < 0.001). The AuROC curve of the validation cohort increased to 0.775 (95% CI 0.750–0.800) when the score was combined with a high NLR. The AuROC of the CARDOT score with the NLR showed significantly greater discrimination power than that of the CARDOT score alone (P = 0.008). Conclusions: The CARDOT score showed a good discriminative performance in the external validation dataset. An addition of a high NLR significantly increases the predictive performance of CARDOT score. The utility of this score is valuable in settings with limited access to preoperative pulmonary function testing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Phrenic neuropathy etiologies and recovery trajectories in outpatient rehabilitation and neuromuscular medicine clinics: A retrospective analysis.
- Author
-
Demetriou, Nicholas, Jensen, Alexandra S., Farr, Ellen, Khanna, Shreyaa, Coleman, John M. III, Ajroud‐Driss, Senda, Adewuyi, Adenike A., Wolfe, Lisa F., and Franz, Colin K.
- Subjects
- *
RESPIRATORY muscles , *PULMONARY function tests , *INTENSIVE care units , *NATURAL history , *PHYSICIANS - Abstract
Introduction/Aims Methods Results Discussion Phrenic neuropathy (PhN) impairs diaphragm muscle function, causing a spectrum of breathing disability. PhN etiologies and their natural history are ill‐defined. This knowledge gap hinders informed prognosis and management decisions. This study aims to help fill this knowledge gap on PhN etiologies, outcomes, and recovery patterns, especially in the context of nonsurgical clinical practice.This was a retrospective study from two interdisciplinary clinics, physiatry and neurology based. Patients were included if PhN was identified, and other causes of hemi‐diaphragm muscle dysfunction excluded. Patients were followed serially at the discretion of the neuromuscular‐trained neurologist or physiatrist. Recovery was assessed using pulmonary function tests (PFTs), diaphragm muscle ultrasound (US) thickening ratio, and patient‐reported outcomes in patients presenting within 2 years of PhN onset.We identified 151 patients with PhN. The most common etiologies were idiopathic (27%), associated with cardiothoracic procedure (24%), and intensive care unit (17%). Of these patients, 117 (77%) were evaluated within 2 years of PhN onset. Of patients included in outcome analyses, 64% saw improvement on serial US, 50% on serial PFTs and 79% reported symptomatic improvement at an average of 15, 16, and 17 months, respectively.A clear majority of PhN patients show improvement in diaphragm muscle function, but on average, improvements took 15–17 months depending on the assessment type. These insights are vital for developing tailored treatments and can guide physicians in prognosis and decision‐making, especially if more invasive interventions are being considered. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Chorioamnionitis and respiratory outcomes in prematurely born children: a systematic review and meta analysis.
- Author
-
Jeffreys, Eleanor, Jenkinson, Allan, Dassios, Theodore, and Greenough, Anne
- Subjects
- *
VITAL capacity (Respiration) , *EXPIRATORY flow , *ASTHMA in children , *PULMONARY function tests , *CHORIOAMNIONITIS - Abstract
To conduct a systematic review and meta-analysis of the association between chorioamnionitis and respiratory outcomes of prematurely born children.Pubmed, Medline and Embase were searched for relevant studies. Studies were included if they assessed prematurely born children, who had been exposed to chorioamnionitis and had either lung function testing or assessment of wheeze or asthma following NICU discharge. Two reviewers independently screened the search results, applied inclusion criteria and assessed methodological quality. One reviewer extracted the data and these were checked by a second reviewer.1,237 studies were identified, but only eight which included 35,000 infants, fulfilled the inclusion criteria. One study looked at both lung function results and wheeze or asthma in childhood. Four of five studies found an association between wheeze/asthma in childhood and exposure to chorioamnionitis: the overall Odds Ratio (OR) for developing wheeze/asthma in childhood was OR 1.71 (95 % CI: 1.55–1.89). Four studies looked at lung function in childhood, three of which showed no statistically significant association between chorioamnionitis exposure and altered lung function. One study found lower lung function in those exposed to chorioamnionitis and lower expiratory flows with increasing levels of chorioamnionitis (forced expiratory flow at 50 % of exhaled forced vital capacity (=FEF50) p=0.012, forced expiratory flow at 25–75 % of the forced vital capacity is exhaled (=FEF25–75) p=0.014).There was a significant association between chorioamnionitis and the development of wheeze or asthma in childhood, but overall not in impairment of lung function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Epidemiology of supplemental oxygen in patients with pulmonary hypertension.
- Author
-
Torres‐Castro, Rodrigo, Hinojosa, Williams, Martínez‐Meñaca, Amaya, Sala Llinas, Ernest, Jiménez Arjona, Josefa, Rueda Soriano, Joaquín, Aurtenetxe, Agueda, Barberà, Joan Albert, Escribano‐Subías, Pilar, and Blanco, Isabel
- Subjects
- *
PULMONARY arterial hypertension , *PULMONARY hypertension , *PULMONARY function tests , *HYPERTENSION , *OXYGEN therapy - Abstract
Background and Objective Methods Results Conclusion Patients with pulmonary hypertension (PH) may present with hypoxaemia at rest or during daily activities. There is no epidemiological data on the prescription of long‐term oxygen therapy (LTOT) in patients with PH. The study sought to analyse the prevalence and incidence of LTOT prescription among patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) in Spain and to determine predictors for this prescription.A retrospective analysis was performed from the Spanish Registry of Pulmonary Arterial Hypertension (REHAP). Collected data included demographics and anthropometric measurements, functional class (FC), arterial blood gases, pulmonary function tests, haemodynamic measurements, six‐minute walking distance (6MWD) and LTOT prescription. In addition, we assessed the prevalence and incidence of LTOT prescription by PH group and subtype and potential predictors for LTOT initiation in the first 5 years after diagnosis.We analysed 4533 patients (69.9% PAH and 30.1% CTEPH), mostly female (64.5%), with a mean age of 53.0 ± 18.3 years. The prevalence of LTOT was 19.3% for all patients. The incidence of LTOT prescriptions decreased from 5.6% to 1.6% between 2010 and 2019, respectively. Predictors for LTOT prescription, excluding those that represent the indication for oxygen therapy were: FC (HR: 1.813), 6MWD (HR: 1.002), mean pulmonary arterial pressure (mPAP) (HR: 1.014), cardiac index (CI) (HR: 1.253), pulmonary vascular resistance (PVR) (HR: 1.023) and diffusing capacity of carbon monoxide (DLCO) (HR: 1.294).The prevalence of LTOT in PAH and CTEPH patients is close to 20%. FC, 6MWD, mPAP, CI, PVR and DLCO were predictors for LTOT prescription. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Cystic lung in sarcoidosis: Clinico‐radiologic characteristic and evolution.
- Author
-
Franco, Giovanni, Debray, Marie‐Pierre, Anzani, Niccolò, Marruchella, Almerico, Cazes, Aurélie, Le Guen, Pierre, Taillé, Camille, Faverio, Paola, Borie, Raphaël, Luppi, Fabrizio, and Crestani, Bruno
- Subjects
- *
VITAL capacity (Respiration) , *PULMONARY function tests , *LUNG diseases , *CARBON monoxide , *SARCOIDOSIS , *CONFIDENCE intervals - Abstract
Background and Objective Methods Results Conclusion Sarcoidosis can manifest with atypical findings on chest computed tomography (CT). Cysts are a rare manifestation of lung sarcoidosis. The aim of the study was to describe a series of patients with cystic sarcoidosis and their clinical‐radiological characteristics and progression.In this retrospective, bicentric study we recruited all patients affected by sarcoidosis with lung cystic lesions at chest CT. We collected clinical characteristics, pulmonary tests and tracked number, distribution and size of the cysts at diagnosis and at the last evaluation.Twelve patients (6 males, median age 53 years) were identified (prevalence: 1.9%; 95% Confidence Interval: 0.8%–2.9%). All patients presented multiple cystic lesions (median number: 14 [range: 2–216]) with a bilateral distribution in 10/12, micronodules and nodules in 11/12 and fibrotic lesions in 4/12. Seven patients had normal lung function test, three had an obstructive syndrome, one had a restrictive syndrome and one had coexistence of both. During follow‐up (median: 10 years [range 1–16 years]), an increase of the number of cysts was observed in four patients. At last evaluation, 3/12 patients experienced a decline of forced vital capacity >10% and 3/12 patients a decline of diffusing capacity for carbon monoxide (DLCO) >10%. A lower DLCO at diagnosis, and the presence of nodules or fibrotic lesions on CT were associated with an increase in the number of cysts.Cystic lung lesions are rare in patients with sarcoidosis and do not influence long term prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Modelling the long-term health impact of COVID-19 using Graphical Chain Models brief heading: long COVID prediction by graphical chain models.
- Author
-
Gourgoura, K., Rivadeneyra, P., Stanghellini, E., Caroni, C., Bartolucci, F., Curcio, R., Bartoli, S., Ferranti, R., Folletti, I., Cavallo, M., Sanesi, L., Dominioni, I., Santoni, E., Morgana, G., Pasticci, M. B., Pucci, G., and Vaudo, G.
- Subjects
- *
POST-acute COVID-19 syndrome , *COVID-19 , *SYMPTOMS , *PULMONARY function tests , *EXERCISE tests - Abstract
Background: Long-term sequelae of SARS-CoV-2 infection, namely long COVID syndrome, affect about 10% of severe COVID-19 survivors. This condition includes several physical symptoms and objective measures of organ dysfunction resulting from a complex interaction between individual predisposing factors and the acute manifestation of disease. We aimed at describing the complexity of the relationship between long COVID symptoms and their predictors in a population of survivors of hospitalization for severe COVID-19-related pneumonia using a Graphical Chain Model (GCM). Methods: 96 patients with severe COVID-19 hospitalized in a non-intensive ward at the "Santa Maria" University Hospital, Terni, Italy, were followed up at 3–6 months. Data regarding present and previous clinical status, drug treatment, findings recorded during the in-hospital phase, presence of symptoms and signs of organ damage at follow-up were collected. Static and dynamic cardiac and respiratory parameters were evaluated by resting pulmonary function test, echocardiography, high-resolution chest tomography (HRCT) and cardiopulmonary exercise testing (CPET). Results: Twelve clinically most relevant factors were identified and partitioned into four ordered blocks in the GCM: block 1 - gender, smoking, age and body mass index (BMI); block 2 - admission to the intensive care unit (ICU) and length of follow-up in days; block 3 - peak oxygen consumption (VO2), forced expiratory volume at first second (FEV1), D-dimer levels, depression score and presence of fatigue; block 4 - HRCT pathological findings. Higher BMI and smoking had a significant impact on the probability of a patient's admission to ICU. VO2 showed dependency on length of follow-up. FEV1 was related to the self-assessed indicator of fatigue, and, in turn, fatigue was significantly associated with the depression score. Notably, neither fatigue nor depression depended on variables in block 2, including length of follow-up. Conclusions: The biological plausibility of the relationships between variables demonstrated by the GCM validates the efficacy of this approach as a valuable statistical tool for elucidating structural features, such as conditional dependencies and associations. This promising method holds potential for exploring the long-term health repercussions of COVID-19 by identifying predictive factors and establishing suitable therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Utility of exhaled nitric oxide to guide mild asthma treatment in atopic patients and its correlation with asthma control test score: a randomized controlled trial.
- Author
-
Pesantes, Edwin, Hernando, Rosana, Lores, Carmen, Cámara, Jonathan, Arévalo, Elías, and Lores, Luis
- Subjects
PULMONARY function tests ,ASTHMATICS ,RANDOMIZED controlled trials ,MEDICAL needs assessment ,CLINICAL trials - Abstract
Background: Fractional exhaled nitric oxide (FeNO) is used for the diagnosis and monitoring of asthma, although its utility to guide treatment and its correlation with other tools is still under discussion. We study the possibility to withdraw inhaled corticosteroid treatment in atopic patients with mild asthma based on the FeNO level, as well as to study its correlation with other clinical control tools. Methods: Prospective and randomized study including atopic patients aged 18 to 65 with mild asthma, stable, on low-dose inhaled corticosteroid (ICS) treatment, who had their treatment withdrawn based on a FeNO level of 40 ppb. Patients were randomized into two groups: control group (treatment with ICS was withdrawn regardless of FeNO level) and experimental group (according to the FeNO levels, patients were assigned to one of two groups: FeNO > 40 ppb on treatment with budesonide 200 mcg every 12 h and SABA on demand; FeNO ≤ 40 ppb only with SABA on demand). Follow-up was conducted for one year, during which medical assessment was performed with FeNO measurements, asthma control test (ACT), lung function tests (FEV1, FEV1/FVC, PEF, and RV/TLC), and recording of the number of exacerbations. Results: Ninety-two patients were included, with a mean age of 39.92 years (SD 13.99); 46 patients were assigned to the control group, and 46 patients to the experimental group. The number of exacerbations was similar between the groups (p = 0.301), while the time to the first exacerbation was significantly shorter in the control group (30.86 vs. 99.00 days), p < 0.001, 95% CI (43.332—92.954). Lung function tests (FEV1, FEV1/FVC, PEF, and RV/TLC) showed no differences between the groups (p > 0.05). Both FeNO and ACT showed significant changes in the groups in which ICS was withdrawn (p < 0.05 for both parameters). A significant negative correlation was observed between FeNO and ACT (r = -0.139, p = 0.008). Conclusions: In atopic patients with mild asthma, withdrawal of ICS based on an FeNO of 40 ppb led to worsened symptoms but without changes in lung function tests or an increase in exacerbations. There was a negative correlation between FeNO values and symptomatic control measured by the ACT. Trial registration: Clinical Trial Number: 2012–000372-42. Start Date: 2012–07-23. Trial registered prospectively (https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-000372-42). This study adheres to CONSORT guidelines of randomised control trials. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Determinants of cough-related quality of life in interstitial lung diseases.
- Author
-
Saari, Eeva, Mononen, Minna, Hasala, Hannele, Nurmi, Hanna, Kettunen, Hannu-Pekka, Suoranta, Sanna, Lappi-Blanco, Elisa, Kaarteenaho, Riitta, Purokivi, Minna, and Koskela, Heikki Olavi
- Subjects
CHRONIC cough ,INTERSTITIAL lung diseases ,PULMONARY function tests ,VITAL capacity (Respiration) ,CARBON monoxide ,COUGH - Abstract
Background: Interstitial lung diseases (ILD) include a wide range of diseases impacting lung parenchyma and leading to fibrosis and architectural distortion. Chronic cough and dyspnea are common symptoms which affect the quality of life (QoL) in ILD patients. The mechanisms of cough in ILD patients are still unknown. The aim of this study was to prospectively investigate histological, radiological, and physiological determinants of cough-related QoL in ILD patients who underwent transbronchial lung cryobiopsy (TBLC). Methods: All patients (n = 111) filled in The Leicester Cough Questionnaire (LCQ) and The St George's Respiratory Questionnaire (SGRQ). They underwent lung function tests, forced vital capacity (FVC), forced vital expiratory volume in 1 s (FEV1), diffusion capacity to carbon monoxide (DLCO), high-resolution computed tomography (HRCT), and blood samples before diagnostic TBLC. Two experienced radiologists assessed the extents of following HRCT patterns: ground-glass opacities (GGO), honeycombing, reticulation, traction bronchiectasis, and emphysema. Histology of TBLC were re-analyzed by two experienced pulmonary pathologists and the presence of fibroblast foci, fibrosis, giant cells, granulomas, and honeycombing were recorded. Results: In the median multivariate regression analysis, BMI (-0.19; 95% CI -0.37- -0.014; p 0.035), GGO (-0.38; 95% CI -0.61- -0.15; p 0.001), granulomas (-3.21; 95% CI -6.12- -0.30; p 0.031), and current smoking (2.49; 95% CI 0.12–4.86; p 0.040) showed independent associations with LCQ total score. BMI (1.3; 95% CI 0.20–2.42; p 0.021) and DLCO (-0.51; 95% CI -0.85 - -0.16; p 0.004) showed independent association with SGRQ total score. Conclusion: Determinants of cough-related QoL in ILD patients are multifactorial including physiological, radiological and histological parameters. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. SPECT/CT to quantify early small airway disease and its relationship to clinical symptoms in smokers with normal lung function: a pilot study.
- Author
-
Juneau, Daniel, Leblond, Antoine, Chatta, Rami, Lévesque, Valérie, Lussier, Annabelle, and Dubé, Bruno-Pierre
- Subjects
SINGLE-photon emission computed tomography ,FORCED expiratory volume ,PULMONARY function tests ,KIRKENDALL effect ,VITAL capacity (Respiration) - Abstract
Introduction: Smokers frequently display respiratory symptoms despite the fact that their pulmonary function tests (PFTs) can be normal. Quantitative lung ventilation single-photon emission computed tomography (SPECT/CT) can provide a quantification of lung ventilatory homogeneity and could prove useful as an early marker of airway disease in smokers. We measured the effects of smoking on regional ventilation distribution in subjects with normal lung function and evaluated whether ventilation distribution in these subjects is related to lung function tests results and clinical symptoms. Methods: Subjects without any history of respiratory disease were prospectively recruited and separated in two groups: active smokers (AS: =10 cigarettes/day and history of =15 pack-years) and never smokers (NS: lifetime exposure of <5 cigarettes). All subjects performed PFTs (which had to be normal, defined as zscore values of forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, total lung capacity (TLC) residual volume and diffusion capacity (DLCO) all falling between -1.65 and +1.65) and underwent SPECT/CT with Technegas, which generated subject-specific ventilation heterogeneity maps. The area under the compensated coefficient of variation (CV) density curve for CV values > 40%, (AUC-CV40%) was used as the measure of ventilation heterogeneity. Results: 30 subjects were recruited (15 per group). Subjects in the AS group displayed higher dyspnea levels (1 [1-2] vs. 0 [0-1] units on mMRC scale, p < 0.001). AUC-CV40% was significantly higher in the AS group (0.386 ± 0.106 vs. 0.293 ± 0.069, p = 0.004). AUC-CV40% was significantly correlated to FEV1 (rho = -0.47, p = 0.009), DLCO (rho = -0.49, p = 0.006), CAT score (rho = 0.55, p = 0.002) and mMRC score (rho = 0.54, p = 0.002). Subjects with mMRC >0 had higher AUC-CV40% values than those without dyspnea (0.289 ± 0.071 vs. 0.378 ± 0.102, p = 0.006), while FEV1 and DLCO were not different between those groups. ROC analyses showed that the AUC for AUC-CV40% in identifying subjects with mMRC score >0 was 0.78 (95%CI 0.61-0.95, p = 0.009), which was significantly higher than that of FEV1 and DLCO. Discussion: In smokers with normal lung function, ventilatory inhomogeneities can be quantified using SPECT/CT. AUC-CV40% values are related to lung function decline and to respiratory symptomatology, suggesting a potential role for this marker in the evaluation of symptomatic smokers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Association of peak expiratory flow with motoric cognitive risk syndrome among older adults.
- Author
-
Hui Xu, Xiangwen Gong, Kaiwang Cui, Xuerui Li, Long Chen, Yiyi Lu, Yangfang Liao, and Jianping Liu
- Subjects
COGNITION disorder risk factors ,RISK assessment ,CROSS-sectional method ,PULMONARY function tests ,RESEARCH funding ,DESCRIPTIVE statistics ,DISEASE prevalence ,EXPIRATORY flow ,LONGITUDINAL method ,ODDS ratio ,WALKING speed ,CONFIDENCE intervals ,DATA analysis software ,OLD age - Abstract
Background: The association between lung function and motoric cognitive risk syndrome (MCR) is unclear. We aimed to explore the association of peak expiratory flow (PEF) with MCR using cross-sectional and longitudinal analyses. Methods: Within the CHARLS, 5095 participants were included in the cross-sectional analysis, and 4340 MCR-free participants were included in the longitudinal analysis. The PEF was assessed with a lung peak flow meter. MCR was characterized by cognitive complaints and a slow walking speed with normal mobility and without dementia. Logistic regression, Cox regression, and Laplace regression models were employed for data analysis. Results: In this cross-sectional study, logistic regression analyses revealed that continuous PEF was associated with MCR (odds ratio [OR], 0.998; 95% confidence interval [CI], 0.998, 0.999), and the ORs (95% CIs) of MCR prevalence were 0.857 (0.693, 1.061) for the middle tertile and 0.665 (0.524, 0.845) for the highest tertile compared to the lowest tertile. In a longitudinal cohort study, continuous PEF was dose-dependently associated with the risk of MCR. Compared with those in the lowest tertile of PEF, the hazard ratios (95% CIs) of incident MCR were 0.827 (0.661, 1,036) for the middle tertile and 0.576 (0.432, 0.767) for the highest tertile. Furthermore, compared with the lowest tertile, the highest tertile was associated with a delayed onset time of MCR of 0.484 (95% CI: 0.151, 0.817) years. Conclusion: A higher PEF was related to a lower prevalence of MCR and a lower risk for MCR, and a higher PEF also prolonged the onset time of MCR. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Effect of antigen removal in hypersensitivity pneumonitis.
- Author
-
Robertshaw, Mark J., Gorman, April, Glazer, Craig S., and Adams, Traci N.
- Subjects
HYPERSENSITIVITY pneumonitis ,PULMONARY function tests ,ANTIGENS ,DIAGNOSIS methods - Abstract
Background: Antigen removal is a cornerstone of treatment of hypersensitivity pneumonitis (HP), but its association with transplant-free survival remains unclear. Further, HP guidelines conflict as to whether antigen removal is a recommended diagnostic test in patients with suspected HP. Objective: The purpose of this study is to (1) evaluate the impact of antigen removal on transplant-free survival and (2) to describe the impact of antigen removal on pulmonary function testing and imaging in a retrospective cohort of patients with HP. Methods: We retrospectively identified HP patients evaluated between 2011 and 2020. Demographic, physiologic, radiographic, and pathologic data were recorded. Results: 212 patients were included in the cohort. Patients who identified and removed antigen had a better transplant-free survival than patients who did not identify antigen and patients who identified but did not remove antigen. Antigen removal was associated with improvement in FVC by 10% predicted in 16.9% of patients with fibrotic HP and 56.7% of patients with nonfibrotic HP. Discussion: Our results suggest that over 50% of nonfibrotic HP patients and 16.9% of fibrotic HP patients improve with exposure removal. In addition, antigen removal, rather than antigen identification, is associated with transplant-free survival in HP. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Effects of spinal mobilisation in adolescent idiopathic scoliosis: A randomised controlled trial.
- Author
-
Küçük, Eylem, Öten, Erol, and Coşkun, Gürsoy
- Subjects
- *
ADOLESCENT idiopathic scoliosis , *FORCED expiratory volume , *VITAL capacity (Respiration) , *EXPIRATORY flow , *PULMONARY function tests - Abstract
Aim Methods Results Conclusion The aim of this study was to evaluate the effects of spinal mobilisation on curvature magnitude, angle of trunk rotation (ATR) and pulmonary function in adolescents with idiopathic scoliosis (AIS).Conducted as a double‐blind randomised controlled trial, the study included 40 patients with AIS (Cobb angles 10°–25°) randomised to experimental (n = 20; female = 12, male = 8; age = 12.9 ± 1.8 mean ± SD) and control (n = 20; female = 13, male = 7; age = 12.85 ± 1.81 mean ± SD) groups. The experimental group received spinal mobilisation for 30 min per session followed by 60 min of core stabilisation exercises (CSE), twice a week for 10 weeks. The control group received CSE only at the same frequency and duration. Evaluation of Cobb angle, ATR and pulmonary function tests (PEF: Peak Expiratory Flow, FEV1: Forced Expiratory Volume in 1 s, FVC: Forced Vital Capacity, and FEV1/FVC: Tiffeneau index) were performed at baseline and after the intervention.Both groups showed significant improvements in Cobb angle, ATR, PEF and FVC, with the experimental group showing significantly greater improvements in Cobb angle (−7.65 ± 3.17) and ATR (−2.5 ± 1.43) compared to the control group (P < 0.05). In addition, while the control group showed no change in FEV1, the experimental group showed improvement. There was no change in FEV1/FVC ratio in either group.These results indicate that adding spinal mobilisation to treatment sessions can effectively reduce the magnitude of curvature and improve scoliosis‐related problems in the short term. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Correlations between blood vessel distribution, lung function and structural change in idiopathic pulmonary fibrosis.
- Author
-
Hu, Po‐Wei, Chen, Chun‐Ku, Hsiao, Yi‐Han, Weng, Ching‐Yao, Lee, Ying‐Chi, Su, Kang‐Cheng, Feng, Jia‐Yih, Chou, Kun‐Ta, Perng, Diahn‐Warng, and Ko, Hsin‐Kuo
- Subjects
- *
IDIOPATHIC pulmonary fibrosis , *PULMONARY fibrosis , *PULMONARY function tests , *IMAGE analysis , *COMPUTED tomography - Abstract
Background and Objective Methods Results Conclusion Correlations between the image analysis of CT scan, lung function and quality of life in patients with idiopathic pulmonary fibrosis (IPF) remain unclear. This study aimed to investigate the impacts of pulmonary blood‐vessel distribution and the extent of fibrosis on the lung function and quality of life of patients with IPF.Patients were enrolled in an IPF registry and had completed pulmonary function tests, chest HRCT, St. George Respiratory Questionnaire (SGRQ) and echocardiography. Pulmonary blood‐vessel distribution, specific image‐derived airway volume (siVaw) and fibrosis extent (siVfib) were quantitatively calculated by functional respiratory imaging on HRCT.The study subjects were categorized into DLco <40% pred. (n = 40) and DLco ≥40% pred. (n = 19) groups. Patients with DLco <40% pred. had significantly higher scores of SGRQ, composite physiologic index (CPI), exercise oxygen desaturation (∆SpO2), siVaw, lower FVC% pred. and 6‐minute walking distance% pred. The proportion of small blood vessels in the upper lobes (BV5PR‐UL) was significantly correlated with CPI, DLco % Pred., FVC% pred., SGRQ and ∆SpO2. Only BV5PR‐UL had a significant impact on all indices but not BV5PR in the lower lobes (BV5PR‐LL). siVfib was significantly negatively correlated with BV5PR‐UL, DLco% pred. and FVC% pred., as well as positively correlated with CPI, ∆SpO2 and siVaw.BV5PR‐UL and siVfib had significant correlations with lung function and may become important indicators to assess the severity of IPF and the impact on quality of life. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Predictive accuracy of the ASIG algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension.
- Author
-
Brown, Zoe, Morrisroe, Kathleen, Hansen, Dylan, Stevens, Wendy, Proudman, Susanna, Teng, Gim G., Low, Andrea, and Nikpour, Mandana
- Subjects
- *
PULMONARY arterial hypertension , *PULMONARY function tests , *SYSTEMIC scleroderma , *MEDICAL screening , *PEPTIDES - Abstract
The Australian Scleroderma Interest Group (ASIG) algorithm for screening pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) requires only respiratory function tests and serum N‐terminal pro‐brain natriuretic peptide as first‐tier tests, and is recommended in international guidelines. In this communication, we present the findings of the application of the ASIG screening algorithm to a Singaporean cohort undergoing prospective annual screening for PAH, which shows a high negative predictive value. The ASIG algorithm may offer an alternative to more complex and costly SSc‐PAH screening algorithms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Effects of home‐based telerehabilitation‐assisted inspiratory muscle training in patients with idiopathic pulmonary fibrosis: A randomized controlled trial.
- Author
-
Aktan, Rıdvan, Tertemiz, Kemal Can, Yiğit, Salih, Özalevli, Sevgi, Ozgen Alpaydin, Aylin, and Uçan, Eyüp Sabri
- Subjects
- *
IDIOPATHIC pulmonary fibrosis , *PULMONARY fibrosis , *INTERSTITIAL lung diseases , *PULMONARY function tests , *MUSCLE strength - Abstract
Background and Objective Methods Results Conclusion There are few studies that have used inspiratory muscle training (IMT) as an intervention for patients with isolated idiopathic pulmonary fibrosis (IPF). This study aimed to investigate and interpret the effects of home‐based telerehabilitation‐assisted IMT in patients with IPF.Twenty‐eight participants with IPF took part in the study. Lung function tests, functional exercise capacity by 6‐min walk distance (6MWD), dyspnoea perception by modified medical research council dyspnoea scale (mMRC), and inspiratory muscle strength by maximal inspiratory pressure (MIP) were assessed. IMT was performed twice a day, 7 days/week, for 8 weeks. The intervention group (n = 14) performed IMT at 50% of their baseline MIP while the control group (n = 14) performed IMT without applied resistance. Loading intensity was progressed by keeping the load at 4–6 on a modified Borg scale for the highest tolerable perceived respiratory effort for each patient.Dyspnoea based on mMRC score (p < 0.001, η2 effect size = 0.48) significantly decreased within the intervention group compared with the control group. There were significant increases in the intervention group compared to the control group based on 6MWD (p < 0.001, η2 effect size = 0.43), MIP (p = 0.006, η2 effect size = 0.25) and MIP % predicted (p = 0.008, η2 effect size = 0.25).The findings of this study suggest that an 8‐week home‐based telerehabilitation‐assisted IMT intervention produced improvements in inspiratory muscle strength, leading to improvements in functional exercise capacity and dyspnoea. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Exploring the associations between elevated plasma SP-D levels and OSCAR gene expression as potential biomarkers in patients with COPD: a cross-sectional study.
- Author
-
Mukhtar, Saima, Choudhry, Nakhshab, Saeed, Saqib, Hanif, Asif, Gondal, Aamir J., and Yasmin, Nighat
- Subjects
FORCED expiratory volume ,VITAL capacity (Respiration) ,PULMONARY surfactant-associated protein D ,PULMONARY function tests ,CHRONIC obstructive pulmonary disease - Abstract
Background: Chronic obstructive pulmonary disease (COPD) imposes a substantial burden on patients and healthcare systems. Spirometry is the most widely used test to diagnose the disease; however, a surrogate marker is required to predict the disease pattern and progression. Objectives: The aim of the current study was to explore the association of elevated levels of plasma surfactant protein D (SP-D) with gene expression of osteoclast-associated receptor (OSCAR) and lung functions as potential diagnostic biomarkers of COPD. Methods: This cross-sectional study employed convenience sampling. As men compose the majority of patients in the outpatient department and with smoking being common among Pakistani men, choosing men offered a representative sample. Using a post-bronchodilator forced expiratory volume in the first second (FEV1) to a forced vital capacity (FVC) of less than 0.70 (FEV1/FVC <0.7), COPD patients were diagnosed on spirometry (n = 41). Controls were healthy individuals with FEV1/FVC >0.7 (n = 41). Plasma SP-D levels were measured using an enzyme-linked immunosorbent assay (ELISA). The gene expression of OSCAR was determined by real-time polymerase chain reaction (qPCR) and subsequently analyzed by the threshold cycle (Ct) method. Statistical Package for Social Sciences (SPSS) version 20 was used for statistical analysis. Results: The mean BMI of controls (25.66 ± 4.17 kg/m2) was higher than that of cases (23.49 ± 2.94 kg/m2 (p = .008)). The median age of controls was 49 years (interquartile range (IQR) 42.0-65.0 years) and that of cases was 65 years (IQR = 57.50-68.50). SP-D concentration was not significantly higher in COPD patients [4.96 ng/mL (IQR 3.26-7.96)] as compared to controls [3.64 ng/mL (IQR 2.60-8.59)] (p = .209). The forced expiratory ratio (FEV1/FVC) and FEV1 were related to gene expression of OSCAR (p = <.001). The gene expression of OSCAR was significantly related to SP-D (p = .034). A multiple regression model found FEV1 and FVC to have a significant effect on the gene expression of OSCAR (p-values <0.001 and 0.001, respectively). Conclusion: Gene expression of OSCAR was increased in COPD patients and related directly to SP-D levels and inversely to lung functions in cohort of this study, suggesting that OSCAR along with SP-D may serve as a diagnostic biomarker of COPD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Prevalence of Forward head posture among car and bike drivers and its relation with neck and cardiopulmonary health parameters- a cross-sectional study.
- Author
-
Aafreen, Aafreen, Khan, Abdur Raheem, Khan, Ashfaque, Ahmad, Ausaf, Shaphe, Mohammad Abu, Alshehri, Mohammed M., Alajam, Ramzi Abdu, Hakamy, Ali, Alqahtani, Abdulfattah S., Ali, Taimul, and Aldhahi, Monira I.
- Subjects
- *
CYCLING , *PULMONARY function tests , *SUBURBS , *FISHER exact test , *TRAFFIC violations - Abstract
Objectives: This study aimed to evaluate and compare the prevalence of Forward Head Posture (FHP) in car and bike drivers, and its potential correlation with neck and cardiopulmonary parameters. Methods: This cross-sectional study involved 400 participants from urban and suburban areas around Lucknow, Uttar Pradesh, India, including 200 car drivers and 200 bike drivers aged 18–65 years with a minimum five-year driving history. Neck health was assessed using measurements such as cervical range of motion and Neck Disability Index (NDI), cardiopulmonary parameters were evaluated through resting heart rate, blood pressure, and pulmonary function tests using the spirometry test, and FHP was assessed using Surgimap application. Statistical analysis was performed using IBM SPSS Statistics software (version 26.0) and included descriptive statistics, hypothesis testing, Chi-square or Fisher's exact test for binary data, and correlation analyses. Results: The result show that difference in the mean FHP between car and bike drivers was statistically significant (p = 0.0001), indicating a higher prevalence of FHP among car drivers than among bike drivers. Correlation analyses revealed significant associations between FHP and neck health metrics, especially cervical flexion (r = 0.71, p<0.05), (r = 0.78, p<0.05) and left-side rotation (r = 0.56, p<0.05), (r = 0.61, p<0.05) in car and bike drivers. Among the cardiopulmonary parameters, significant correlations with FHP were observed in resting heart rate (r = 0.33, p<0.05), (r = 0.42, p<0.05), spirometry results FVC (r = 0.29, p<0.05), FEV1 (r = 0.22, p<0.05), and FVC (r = 0.31, p<0.05) for car and bike drivers. Conclusion: We observed a higher incidence of FHP in car drivers, indicating that a prolonged static posture may lead to greater postural deviation than dynamic movement during biking. This association suggests that FHP could have wide-reaching implications for systemic health, beyond musculoskeletal issues. These findings have the potential to influence preventative strategies and interventions aimed at improving the overall health outcomes for drivers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Therapeutic effect of long-acting muscarinic antagonist for treating uncontrolled asthma assessed using impulse oscillometry.
- Author
-
Sugawara, Hiroyuki, Saito, Atsushi, Yokoyama, Saori, and Chiba, Hirofumi
- Subjects
- *
PULMONARY function tests , *ASTHMATICS , *MUSCARINIC antagonists , *ASTHMA , *TREATMENT effectiveness , *COUGH - Abstract
Background: In recent years, the incorporation of LAMAs into asthma therapy has been expected to enhance symptom control. However, a significant number of patients with asthma continue to experience poorly managed symptoms. There have been limited investigations on LAMA-induced airway alterations in asthma treatment employing IOS. In this study, we administered a LAMA to patients with poorly controlled asthma, evaluated clinical responses and respiratory function, and investigated airway changes facilitated by LAMA treatments using the IOS. Methods: Of a total of 1282 consecutive patients with asthma, 118 exhibited uncontrolled symptoms. Among them, 42 switched their treatment to high-dose fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (ICS/LABA/LAMA). The patients were then assessed using AHQ-33 or LCQ and ACT. Spirometry parameters (such as FEV1 or MMEF) and IOS parameters (such as R20 or AX) were measured and compared before and after exacerbations and the addition of LAMA. Results: Of the 42 patients, 17 who switched to FF/UMEC/VI caused by dyspnea exhibited decreased pulmonary function between period 1 and baseline, followed by an increase in pulmonary function between baseline and period 2. Significant differences were observed in IOS parameters such as R20, R5-R20, Fres, or AX between period 1 and baseline as well as between baseline and period 2. Among the patients who switched to inhaler due to cough, 25 were classified as responders (n = 17) and nonresponders (n = 8) based on treatment outcomes. Among nonresponders, there were no significant differences in spirometry parameters such as FEV1 or PEF and IOS parameters such as R20 or AX between period 1 and baseline. However, among responders, significant differences were observed in all IOS parameters, though not in most spirometry parameters, between period 1 and baseline. Furthermore, significant differences were noted between baseline and period 2 in terms of FEV1, %MMEF, %PEF, and all IOS parameters. Conclusion: ICS/LABA/LAMA demonstrates superiority over ICS/LABA in improving symptoms and lung function, which is primarily attributed to the addition of LAMA. Additionally, IOS revealed the effectiveness of LAMA across all airway segments, particularly in the periphery. Hence, LAMA can be effective against various asthma phenotypes characterized by airway inflammation, even in real-world cases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Fitness Level- and Sex-Related Differences in Pulmonary Limitations to Maximal Exercise in Normoxia and Hypoxia.
- Author
-
RABERIN, ANTOINE, MANFERDELLI, GIORGIO, SCHORDERET, FORREST, BOURDILLON, NICOLAS, and MILLET, GRÉGOIRE P.
- Subjects
- *
PULMONARY function tests , *EXERCISE , *SEX distribution , *RESPIRATION , *EXERCISE intensity , *DESCRIPTIVE statistics , *CYCLING , *PHYSICAL fitness , *FORCED expiratory volume , *OXYGEN consumption , *ENDURANCE sports training , *HYPOXEMIA - Abstract
Purpose: Bothmaximal-intensity exercise and altitude exposure challenge the pulmonary system that may reach itsmaximal capacities. Expiratory flow limitation (EFL) and exercise-induced hypoxemia (EIH) are common in endurance-trained athletes. Furthermore, because of their smaller airways and lung size, women, independently of their fitness level, may be more prone to pulmonary limitations duringmaximalintensity exercise, particularly when performed in hypoxic conditions. The objective of this study was to investigate the impact of sex and fitness level on pulmonary limitations during maximal exercise in normoxia and their consequences in acute hypoxia. Methods: Fifty-one participants were distributed across four different groups according to sex and fitness level. Participants visited the laboratory on three occasions to perform maximal incremental cycling tests in normoxia and hypoxia (inspired oxygen fraction = 0.14) and two hypoxic chemosensitivity tests. Pulmonary function and ventilatory capacities were evaluated at each visit. Results: EIH was more prevalent (62.5% vs 22.2%, P = 0.004) and EFL less common (37.5% vs 70.4%, P = 0.019) in women than men. EIH prevalence was different (P = 0.004) between groups of trained men (41.7%), control men (6.7%), trained women (50.0%), and control women (75.0%). All EIH men but only 40% of EIH women exhibited EFL. EFL individuals had higher slope ratio (P = 0.029), higher ventilation (VE) (P < 0.001), larger ΔVO2max (P = 0.019), and lower hypoxia-relatedV E increase (P < 0.001). Conclusions: Women reported a higher EIH prevalence than men, regardless of their fitness level, despite a lower EFL prevalence. EFL seems mainly due to the imbalance between ventilatory demands and capacities. It restricts ventilation, leading to a larger performance impairment during maximal exercise in hypoxic conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. There is no association between serum endotoxin levels and inflammation in asthma.
- Author
-
Candan, Ozlem, Toptas, Tayfur, Demir, Semra, and Erdenen, Fusun
- Subjects
- *
ENDOTOXINS , *ASTHMA , *GRAM-negative bacteria , *LIPOPOLYSACCHARIDE structure , *PULMONARY function tests , *WHEEZE - Abstract
Endotoxin, in lipopolysaccharide structure (LPS), is the main component of the outer membrane of gram negative bacteria. LPS levels were associated with inflammatory disease. Asthma is a chronic inflammatory disease involving many different cell types and cellular elements. The association between LPS serum levels and the asthma is not well known. The aim of this study was to investigate the association between the LPS serum levels and the severity of asthma, demographic data and laboratory parameters. The study included 67 patients aged >18 years with a diagnosis of asthma, and 15 healthy volunteers with no history of chronic disease as a control group. The Asthma Control Test (ACT), Respiratory Function Tests (RFTs), fractional exhaled nitric oxide (FeNO), and endotoxin levels were measured and compared between the groups. The endotoxin measurements were performed using the ELISA method. The mild-moderate asthma group included 33 patients and the severe asthma group, 34 patients. The endotoxin level was measured as 17.78 (range 3.59 to 304.55) EU/ml in the patient group and 15 (range 4.01 to 74.06) EU/ml in the control group with no statistically significant difference determined between the groups. In the subgroups, the endotoxin level was measured as 15.21 (range 3.69 to 304.55) EU/ml in the mild-moderate group and 14.46 (range 3.59 to 278.86) EU/ml in the severe asthma group with no statistically significant difference determined between the groups. The results of this study showed no relationship between serum endotoxin level and asthma or asthma severity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Anti-IL-5 and anti-IL-5R biologics for severe asthma. Are there any differences in their effects?
- Author
-
Granda, Paula, Villamañán, Elena, Carpio, Carlos, Laorden, Daniel, Quirce, Santiago, and Álvarez-Sala, Rodolfo
- Subjects
- *
EMERGENCY room visits , *ASTHMA , *PULMONARY function tests , *PULMONARY eosinophilia , *BIOLOGICALS , *VOCAL cord dysfunction , *HOSPITAL admission & discharge - Abstract
The aim of this retrospective multicentre study is to describe the clinical characteristics of patients diagnosed with severe eosinophilic asthma receiving anti-IL-5/anti-IL-5Rα therapies and to compare their effectiveness. We collected and analysed results separately for anti-IL-5 and anti-IL-5Rα therapies from January 2016 until December 2021 in multidisciplinary severe asthma units. We collected demographic and clinical data, treatment with previous anti-IgE and/or anti-IL-5 agents, and comorbidities. We compared the number of exacerbations and admissions to the hospital, daily oral corticosteroid intake, pulmonary function tests, and Asthma Control Test scores before and after 12 months of therapy. 261 patients were included: 176 patients in the anti-IL-5 group and 85 in the anti-IL-5Rα group. Both groups led to statistically significant reductions in asthma exacerbations, hospital admissions, and visits to the Emergency Room. Although both groups showed a significant reduction in blood eosinophiliccount, we found a difference, although not significant, in the magnitude of reduction as benralizumab was able to decrease eosinophil counts to zero. Patients in the anti-IL-5 group achieved higher ACT scores after treatment, although this improvement was seen in both treatment groups. The anti-IL-5 and anti-IL-5Rα biologics have shown similar effectiveness despite having different mechanisms of action. The anti-IL-5 group appeared to be better than benralizumab at improving ACT scores and FEV1/FVC and at reducing the number of inhalers. Although these differences were not statistically significant, it is not clear whether they may have clinical relevance and they might highlight the need for further head-to-head studies comparing these treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Associations of personal urinary volatile organic compounds and lung function in children.
- Author
-
Park, Dawon, Ha, Eun Kyo, Jung, Haeri, Kim, Ju Hee, Shin, Jeewon, Kim, Mi Ae, Shin, Youn Ho, Jee, Hye Mi, and Han, Man Yong
- Subjects
- *
VOLATILE organic compounds , *FORCED expiratory volume , *VITAL capacity (Respiration) , *LUNGS , *PULMONARY function tests - Abstract
We investigated the correlation between urine VOC metabolites and airway function in children exposed to anthropogenic volatile organic compounds (VOCs), notable pollutants impacting respiratory health. Out of 157 respondents, 141 completed skin prick tests, spirometry, IOS, and provided urine samples following the International Study of Asthma and Allergies in Childhood (ISAAC)-related questions. Allergic sensitization was assessed through skin prick tests, and airway functions were evaluated using spirometry and impulse oscillometry (IOS). Forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) was recorded and FEV1/FVC ratio was calculated. Airway mechanics parameters including respiratory resistance at 5 Hz (Rrs5) mean respiratory resistance between 5 Hz and 20 Hz (Rrs5–20), were also recorded. Urine concentrations of metabolites of benzene, ethylbenzene, toluene, xylene, styrene, formaldehyde, carbon-disulfide were analyzed by gas chromatography/tandem mass spectroscopy. The median age at study participation was 7.1 (SD 0.3) years. Muconic acid (benzene metabolites) and o-methyl-hippuric acid (xylene metabolites) above medians were associated with a significant increase in Rrs5 (muconic acid: aβ = 0.150, p =.002; o-methyl-hippuric acid: aβ = 0.143, p =.023) and a decrease in FEV1/FVC (o-methyl-hippuric acid: aβ = 0.054, p =.028) compared to those below median. No associations were observed for Rrs5–20 and FEV1 between the groups categorized as above and below the median (all parameter p values >.05). Elevated levels of benzene and xylene metabolites were associated with a significant increase in Rrs5 and a decrease in FEV1/FVC, related to increased resistance and restrictive lung conditions compared to individuals with concentrations below the median. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Reliability and validity of cough peak flow measurements in myasthenia gravis.
- Author
-
Kuroiwa, Ryota, Shibuya, Kazumoto, Inagaki, Takeshi, Nara, Takeru, Nemoto, Marie, Doi, Yuka, Yasuda, Manato, Uzawa, Akiyuki, Shiko, Yuki, Murata, Atsushi, Yamanaka, Yoshitaka, and Kuwabara, Satoshi
- Subjects
- *
FLOW measurement , *COUGH , *PULMONARY function tests , *INTRACLASS correlation , *FLOW meters , *MYASTHENIA gravis - Abstract
• The cough peak flow measurement has high measurement reliability in patients with myasthenia gravis (MG) before and after immunotherapy. • Cough peak flow measurement is correlated with respiratory function and MG symptoms. • Cough peak flow measurement is a useful self-monitoring tool for MG symptoms. Decreased cough strength in myasthenia gravis (MG) leads to aspiration and increases the risk of MG crisis. The aim of this study was to clarify the reliability and validity of cough peak flow (CPF) measurements in MG. A total of 26 patients with MG who underwent CPF measurements using the peak flow meter by themselves were included. MG symptoms were evaluated by pulmonary function tests and clinical MG assessment scales before and after immune-treatments. The relationship between CPF and pulmonary function tests and MG comprehensive were assessed. The cut-off value of CPF for aspiration risk was determined and the area under the curve (AUC) was calculated. The intraclass correlation coefficient was more than 0.95 for pre-and post-treatment. Positive correlations were found between CPF and almost all spirometric values as well as between the differences of pre-and post-treatment in CPF and quantitative myasthenia gravis score. The CPF for identifying the aspiration risk was used to calculate the CPF cut-off value of 205 L/min with a sensitivity of 0.77, specificity of 0.90, and AUC of 0.85. The CPF, a convenient measure by patients themselves, has a high reliability in patients with MG, and is a useful biomarker reflecting MG symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
- Author
-
Johnson, Sindhu R., Bernstein, Elana J., Bolster, Marcy B., Chung, Jonathan H., Danoff, Sonye K., George, Michael D., Khanna, Dinesh, Guyatt, Gordon, Mirza, Reza D., Aggarwal, Rohit, Allen, Aberdeen, Assassi, Shervin, Buckley, Lenore, Chami, Hassan A., Corwin, Douglas S., Dellaripa, Paul F., Domsic, Robyn T., Doyle, Tracy J., Falardeau, Catherine Marie, and Frech, Tracy M.
- Subjects
- *
MEDICAL protocols , *PULMONARY function tests , *BIOPSY , *OXYGEN saturation , *PROFESSIONAL associations , *INTERSTITIAL lung diseases , *CHEST X rays , *SYSTEMATIC reviews , *VOTING , *AUTOIMMUNE diseases , *PATIENT monitoring , *BRONCHOSCOPY , *RHEUMATISM , *DISEASE risk factors , *DISEASE complications - Abstract
Objective: We provide evidence‐based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies, mixed connective tissue disease, and Sjögren disease. Methods: We developed clinically relevant population, intervention, comparator, and outcomes questions related to screening and monitoring for ILD in patients with SARDs. A systematic literature review was performed, and the available evidence was rated using the Grading of Recommendations, Assessment, Development, and Evaluation methodology. A Voting Panel of interdisciplinary clinician experts and patients achieved consensus on the direction and strength of each recommendation. Results: Fifteen recommendations were developed. For screening people with these SARDs at risk for ILD, we conditionally recommend pulmonary function tests (PFTs) and high‐resolution computed tomography of the chest (HRCT chest); conditionally recommend against screening with 6‐minute walk test distance (6MWD), chest radiography, ambulatory desaturation testing, or bronchoscopy; and strongly recommend against screening with surgical lung biopsy. We conditionally recommend monitoring ILD with PFTs, HRCT chest, and ambulatory desaturation testing and conditionally recommend against monitoring with 6MWD, chest radiography, or bronchoscopy. We provide guidance on ILD risk factors and suggestions on frequency of testing to evaluate for the development of ILD in people with SARDs. Conclusion: This clinical practice guideline presents the first recommendations endorsed by the American College of Rheumatology and American College of Chest Physicians for the screening and monitoring of ILD in people with SARDs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Diagnostic insights from chemometric analysis of hemogram inflammatory indexes in male smokers with and without asthma or chronic obstructive pulmonary disease.
- Author
-
Singh, Brajesh, Dutta, Vijay, Singh, Smiti, and Pundit, Priyanka
- Subjects
- *
CHEMOMETRICS , *PULMONARY function tests , *PEARSON correlation (Statistics) , *NEUTROPHIL lymphocyte ratio , *RECEIVER operating characteristic curves , *SMOKING , *PSYCHOLOGY of men , *BLOOD cell count , *MULTIVARIATE analysis , *MONOCYTE lymphocyte ratio , *OBSTRUCTIVE lung diseases , *ASTHMA , *SENSITIVITY & specificity (Statistics) - Abstract
Background: Diagnosis of asthma and chronic obstructive pulmonary disease (COPD) becomes difficult in a primary healthcare center due to ambiguous interpretation of spirometry and lack of facility to access established biomarkers. While routine hematological indices are easily available and accessible. The study aimed to evaluate the role of different hemogram indexes in males in COPD, asthma, and healthy smokers. Materials and Methods: Lung function tests and complete blood count (CBC) were done for 50 male subjects each from asthma, COPD, and healthy smokers. Multivariate analysis (MVA) was performed on blood indices data set. Receiver operating characteristic (ROC) curve was plotted to observe the performance of indexes. Pearson correlation was used to establish association between the lung function and blood indices. Results: Most of the indices were elevated in COPD. Whereas, asthma patients showed a significant increase in eosinophil basophil ratio (EBR), lymphocyte‐monocyte ratio (LMR), and mean platelet volume‐platelet count ratio (MPR). Orthogonal (O)‐ Partial Least‐Squares Discriminant Analysis (PLSDA) and variable importance in projection (VIP) score established EBR, neutrophil‐lymphocyte ratio (NLR) and LMR, as discriminants for asthma. Whereas, Systemic Inflammatory Response Index (SIRI), NLR and EBR were the key variables for COPD. NLR (r = −0.73, p < 0.001) and SIRI (r = −0.71, p < 0.001) were found to be negatively correlated with forced expiratory volume in 1 s (FEV1) percentage of the predicted value (%pred) in asthma and COPD, respectively. EBR showed the sensitivity and specificity of 96% and 86% respectively in asthma. NLR was having sensitivity of 82% and 90% specificity in COPD. Conclusion: Our study in males shows routine hematological indices as being cost‐effective, feasible, and seem to have tremendous potential as screening markers among chronic respiratory diseases in a primary healthcare center. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Prognostic value and predictors of the alteration of the diffusing capacity of the lungs for carbon monoxide in systemic lupus erythematosus.
- Author
-
Tallec, Erwan Le, Bourg, Corentin, Bouzillé, Guillaume, Belhomme, Nicolas, Pabic, Estelle Le, Guillot, Stéphanie, Droitcourt, Catherine, Perlat, Antoinette, Jouneau, Stéphane, Donal, Erwan, and Lescoat, Alain
- Subjects
- *
LUNG physiology , *PULMONARY function tests , *PULMONARY gas exchange , *QUALITATIVE research , *PREDICTION models , *MICROCIRCULATION , *SMOKING , *LOGISTIC regression analysis , *SYSTEMIC lupus erythematosus , *SEVERITY of illness index , *RETROSPECTIVE studies , *INTERSTITIAL lung diseases , *QUANTITATIVE research , *MULTIVARIATE analysis , *DESCRIPTIVE statistics , *CONNECTIVE tissue diseases , *ODDS ratio , *KAPLAN-Meier estimator , *LOG-rank test , *CARBON monoxide , *MEDICAL records , *ACQUISITION of data , *STATISTICS , *LUNG volume measurements , *CONFIDENCE intervals , *DATA analysis software , *DIFFUSION - Abstract
Objectives SLE is a systemic autoimmune disease characterized by heterogeneous manifestations and severity, with frequent lung involvement. Among pulmonary function tests, the measure of the diffusing capacity of the lungs for carbon monoxide (DLCO) is a noninvasive and sensitive tool assessing pulmonary microcirculation. Asymptomatic and isolated DLCO alteration has frequently been reported in SLE, but its clinical relevance has not been established. Methods This retrospective study focused on 232 SLE patients fulfilling the 2019 EULAR/ACR classification criteria for SLE. Data were collected from the patient's medical record, including demographic, clinical and immunological characteristics, while DLCO was measured when performing pulmonary function tests as part of routine patient follow-up. Results At the end of follow-up, DLCO alteration (<70% of predicted value) was measured at least once in 154 patients (66.4%), and was associated with a history of smoking as well as interstitial lung disease, but was also associated with renal and neurological involvement. History of smoking, detection of anti-nucleosome autoantibodies and clinical lymphadenopathy at diagnosis were independent predictors of DLCO alteration, while early cutaneous involvement with photosensitivity was a protective factor. DLCO alteration, at baseline or any time during follow-up, was predictive of admission in intensive care unit and/or of all-cause death, both mainly due to severe disease flares and premature cardiovascular complications. Conclusion This study suggests a link between DLCO alteration and disease damage, potentially related to SLE vasculopathy, and a prognostic value of DLCO on death or intensive care unit admission in SLE. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Effectiveness and safety of preoperative distraction using modified halo-pelvic Ilizarov distraction assembly in patients with severe kyphoscoliosis.
- Author
-
Ilyas, Muhammad Saad, Shah, Abdullah, Zehra, Uruj, Ismail, Muhammad, Elahi, Haseeb, and Aziz, Amer
- Subjects
- *
ADOLESCENT idiopathic scoliosis , *BONE lengthening (Orthopedics) , *FORCED expiratory volume , *DISTRACTION , *PULMONARY function tests , *PATIENT compliance , *SPINE abnormalities - Abstract
Study Design: A 2-year follow-up study. Purpose: To evaluate the effectiveness of modified halo-pelvic Ilizarov distraction assembly in the management of patients with severe kyphoscoliosis. Overview of Literature: Severe and rigid scoliosis curves are always a challenge for operating surgeons. Preoperative correction through halo-pelvic devices successfully minimizes the severity of the curve; however, cumbersome complications are also reported with its use. Modified assembly could be safe for these cases. Methods: Patients with severe kyphoscoliosis having coronal Cobb angle >90° were applied with modified halo-pelvic Ilizarov distraction assembly preoperatively. The modified assembly consisted of a pelvic component and halo ring, and distraction was given at the rate of 2–3 mm/day for 6–12 weeks. Complete clinical assessments along with pulmonary function tests were performed, and scoliosis series X-ray images were assessed for coronal and sagittal Cobb angle and other spinopelvic parameters before applying the assembly and during 2 years of follow-up. Results: Thirty-four patients (age, 9–27 years; male/female ratio of 18:16) were included. The coronal and sagittal Cobb angles were 116°±16.2° and 84°±28.3°, respectively. Correction rates obtained through modified halo-pelvic assembly were nearly 52% (p<0.001) in coronal and 40% (p<0.001) in sagittal Cobb angles, with improvement in height (p<0.001). Apical vertebral translation and coronal balance were also improved significantly (p<0.001). Further improvements in all the parameters were obtained after definitive surgery, with improvements in the forced expiratory volume in 1 second (p=0.002) and forced vital capacity (p=0.001). Conclusions: Our modified halo-pelvic Ilizarov distraction assembly can achieve good correction in severe spinal deformities without significant risk to neurology, has fewer complications, and promotes good patient compliance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Assessing pulmonary function in ALS using electrical impedance tomography.
- Author
-
Rutkove, Seward B., McIlduff, Courtney E., Stommel, Elijah, Levy, Sean, Smith, Christy, Gutierrez, Hilda, Verga, Sarah, Samaan, Soleil, Yator, Chebet, Nanda, Ajitesh, Pastel, Lisa, Doussan, Allaire, Phipps, Kathy, Murphy, Ethan, and Halter, Ryan
- Subjects
- *
ELECTRICAL impedance tomography , *PEARSON correlation (Statistics) , *AMYOTROPHIC lateral sclerosis , *PULMONARY function tests , *INTRACLASS correlation - Abstract
We sought to determine whether thoracic electrical impedance tomography (EIT) could characterize pulmonary function in amyotrophic lateral sclerosis (ALS) patients, including those with facial weakness. Thoracic EIT is a noninvasive, technology in which a multi-electrode belt is placed across the chest, producing real-time impedance imaging of the chest during breathing. We enrolled 32 ALS patients and 32 age- and sex-matched healthy controls (HCs) without underlying lung disease. All participants had EIT measurements performed simultaneously with standard pulmonary function tests (PFTs), including slow and forced vital capacity (SVC and FVC) in upright and supine positions and maximal inspiratory and expiratory pressures (MIPs and MEPs, respectively). Intraclass correlation coefficients (ICCs) were calculated to assess the immediate reproducibility of EIT measurements and Pearson's correlations were used to explore the relationships between EIT and PFT values. Data from 30 ALS patients and 27 HCs were analyzed. Immediate upright SVC reproducibility was very high (ICC 0.98). Correlations were generally strongest between EIT and spirometry measures, with R values ranging from 0.64 to 0.82 (p < 0.001) in the ALS cohort. There were less robust correlations between EIT values and both MIPs and MEPs in the ALS patients, with R values ranging from 0.33 to 0.44. There was no significant difference for patients with and without facial weakness. There were no reported adverse events. EIT-based pulmonary measures hold the promise of providing an alternative approach for lung function assessment in ALS patients. Based on these early results, further development and study of this technology are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Evaluation of Stress Scores of Healthy Adult Cats during Barometric Whole-Body Plethysmography and Its Correlation with Measurement Parameters.
- Author
-
Benz, Petra, Zablotski, Yury, and Schulz, Bianka
- Subjects
- *
EFFECT of stress on animals , *PULMONARY function tests , *CATS , *LONGITUDINAL method , *PLETHYSMOGRAPHY , *ASTHMA , *LUNGS - Abstract
Simple Summary: The stress load of cats undergoing lung function diagnostics using barometric whole-body plethysmography has not yet been investigated. In this study, a feline stress score was used to determine the stress level of healthy cats over a 30 min time period during plethysmographic measurement; in addition, the correlation with measured parameters was evaluated. The stress levels of the majority of the 48 cats studied were increased at the beginning of measurements and decreased significantly over time. There was a significant correlation between most measurement parameters and the total stress score. Although the barometric whole-body plethysmography is considered to be a particularly gentle method, most cats initially experienced moderate stress. The stress level must be taken into account when interpreting the measured parameters. Barometric whole-body plethysmography (BWBP) is considered to be a particularly gentle method of assessing lung function in cats. However, there have been no studies to date investigating the stress experienced by cats during measurements. The prospective study included 48 healthy adult cats. Each cat was measured in the plethysmographic chamber for a total of 30 min and stress levels were determined every 10 min using a stress ethogram. At the beginning of measurements, 75% of cats were assessed as tense. Over the three time periods, a significant (p < 0.001) reduction in the total stress score was observed. In addition, all measurement parameters correlated significantly with the stress score, with the exception of enhanced pause and tidal volume. It can therefore be assumed that cats will initially experience stress during examination in the plethysmographic chamber, but stress will decrease significantly over time. As the stress level correlates with many measurement parameters, this should be taken into account when interpreting the results. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Evaluation of the new modified apnea test in confirmation of brain death.
- Author
-
Kashefi, Parviz, Abbasi, Saeed, Kiani, Koosha, Khalifehsoltani Khajoei, Maryam, and Akbari, Mojtaba
- Subjects
- *
MANDATORY medical testing , *PULMONARY function tests , *CROSS-sectional method , *BLOOD gases analysis , *OXYGEN saturation , *PATIENTS , *EVALUATION of medical care , *DESCRIPTIVE statistics , *RESPIRATORY diseases , *BRAIN death , *HEART beat , *CAPNOGRAPHY , *COMPARATIVE studies , *DATA analysis software , *HYPERCAPNIA , *BLOOD pressure , *MECHANICAL ventilators , *HYPOXEMIA - Abstract
Background: Apnea testing is mandatory to confirm brain death; however, it is unsafe for patients who have substantial hypoxemia without ventilator support. We used a new modified apnea test without the need to disconnect the patient from the ventilator in the present study and compared the outcomes and complications of the new method to the widely used old method. Materials and Methods: The current study was conducted on people suspected of having brain death. Both the old and new apnea tests were carried out on the same individual. In the new modified method, instead of hyperventilating and then separating the brain death from the ventilator, the induced hypercapnia method was used, and instead of performing repeated arterial blood gas (ABG), the target ETCO2 was obtained, and at the time of the target ETCO2, ABG was also checked followed by comparing ETCO2 with PaCO2. Results: Thirty patients, including 25 (83.3%) males and 5 (16.75%) females, were included in the study. The results showed significant improvement in terms of O2 saturation and heart rate (HR) using the new modified apnea test compared to the common test. Systolic blood pressure, diastolic blood pressure, and the frequency of complications were improved in the new modified test. Conclusion: The modified apnea test produced better results in terms of O2 saturation, HR, and other clinical factors, while it does not require disconnection from the ventilator and repeated ABG assessment. Therefore, it can be used to successfully diagnose brain death in high-risk individuals suffering from severe hypoxia. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Revealing the Hidden Impacts: Insights into Biological Aging and Long-Term Effects in Pauci- and Asymptomatic COVID-19 Healthcare Workers.
- Author
-
Campisi, Manuela, Cannella, Luana, Bordin, Anna, Moretto, Angelo, Scapellato, Maria Luisa, Mason, Paola, Liviero, Filippo, and Pavanello, Sofia
- Subjects
- *
MEDICAL personnel , *HEART beat , *CELLULAR aging , *PULMONARY function tests , *EQUILIBRIUM testing - Abstract
This study explores the role of inflammation and oxidative stress, hallmarks of COVID-19, in accelerating cellular biological aging. We investigated early molecular markers—DNA methylation age (DNAmAge) and telomere length (TL)—in blood leukocytes, nasal cells (NCs), and induced sputum (IS) one year post-infection in pauci- and asymptomatic healthcare workers (HCWs) infected during the first pandemic wave (February–May 2020), compared to COPD patients, model for "aged lung". Data from questionnaires, Work Ability Index (WAI), blood analyses, autonomic cardiac balance assessments, heart rate variability (HRV), and pulmonary function tests were collected. Elevated leukocyte DNAmAge significantly correlated with advancing age, male sex, daytime work, and an aged phenotype characterized by chronic diseases, elevated LDL and glycemia levels, medications affecting HRV, and declines in lung function, WAI, lymphocyte count, hemoglobin levels, and HRV (p < 0.05). Increasing age, LDL levels, job positions involving intensive patient contact, and higher leukocyte counts collectively contributed to shortened leukocyte TL (p < 0.05). Notably, HCWs exhibited accelerated biological aging in IS cells compared to both blood leukocytes (p ≤ 0.05) and NCs (p < 0.001) and were biologically older than COPD patients (p < 0.05). These findings suggest the need to monitor aging in pauci- and asymptomatic COVID-19 survivors, who represent the majority of the general population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Exercise‐induced bronchoconstriction in adolescent recreational athletes: Potential screening strategies.
- Author
-
Goossens, Janne, Vandekerckhove, Josefien, Jonckheere, Anne‐Charlotte, Dilissen, Ellen, Marain, Nora, Ieven, Toon, De Wilde, Barbara, Leus, Jasmine, Verelst, Sophie, Raes, Marc, Dupont, Lieven, and Bullens, Dominique
- Subjects
- *
PULMONARY function tests , *SKIN tests , *RESPIRATORY therapy , *BIOMARKERS , *AIR pollution - Abstract
Background: Intense physical exercise in athletes increases the risk to develop exercise‐induced bronchocontriction (EIB). We aimed to study EIB prevalence and explore methods for effective EIB screening. Methods: Three hundred twenty‐seven adolescent athletes (12–18 years) performing at least 12 h of sports a week were included. The evaluation consisted of spirometry, eucapnic voluntary hyperpnoea test (EVH) to evaluate for EIB, FeNO, skin prick testing, blood sampling (serum markers of epithelial damage and mast cell activation), and questionnaires (AQUA©, ACT, ACQ, and exposure and symptom‐related questions). Results: Of all athletes, 22% tested positive for EIB (n = 72), 14% reported a previous asthma diagnosis and 40% were atopic. Eighty percent of EIB+ athletes did not use any inhalation therapy. EIB+ athletes were significantly younger, had decreased FEV1/FVC (%), and increased post‐EVH‐reversibility (%) post‐salbutamol compared with EIB− athletes. Furthermore, EIB was significantly associated with previous asthma diagnosis and atopy. The best predictors for a positive EVH test were AQUA© score ≥ 6 (sensitivity of 78%, p =.0171) and wheezing during exercise (specificity of 82%, p =.0002). FeNO negatively and significantly correlated with maximal fall in FEV1 post‐EVH test in atopic athletes (r = −.2735, p =.0056). Maximal fall in FEV1 was also associated with prior PM10 exposure (p =.036). Serum markers of epithelial damage were significantly associated with training type, training intensity, EIB severity, and prior air pollution exposure. Conclusion: Our findings support the effectiveness of a systematic respiratory screening approach, including baseline questionnaires, lung function tests, and FeNO measurement, to improve EIB detection in adolescent athletes in whom respiratory response to EVH testing is associated with prior exposure to air pollution. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Association of temperature and absolute humidity with incidence of exercise‐induced bronchoconstriction in children.
- Author
-
Tikkakoski, Anna P., Reini, Markus, Sipilä, Kalle, Kivistö, Juho E., Karjalainen, Jussi, Kähönen, Mika, Tikkakoski, Antti, and Lehtimäki, Lauri
- Subjects
- *
EXERCISE-induced asthma , *HUMIDITY , *EXERCISE tests , *ASTHMA in children , *OUTDOOR recreation , *VOCAL cord dysfunction - Abstract
Aim: Exercise test outdoors is widely used to diagnose asthma in children, but it is unclear how much outdoor air factors affect the results. Methods: We analysed 321 outdoor exercise challenge tests with spirometry in children 6–16 years conducted due to suspicion of asthma or for assessing the effect of medication on asthma. We studied the association of FEV1 decrease and incidence of exercise‐induced bronchoconstriction (EIB) with temperature, relative humidity (RH) and absolute humidity (AH). Results: Asthma was diagnosed in 57% of the subjects. AH ≥5 g/m3, but not RH or temperature, was associated with the EIB incidence (p = 0.035). In multivariable logistic regression, AH ≥5 g/m3 was negatively associated (OR = 0.51, 95% CI [0.28─0.92], p = 0.026) while obstruction before exercise (OR = 2.11, 95% CI [1.16─3.86], p = 0.015) and IgE‐mediated sensitisation were positively associated with EIB (OR = 2.24, 95% CI [1.11─4.51], p = 0.025). AH (r = −0.12, p = 0.028) and temperature (r = −0.13, p = 0.023) correlated with decrease in FEV1. In multivariable linear regression, only AH was associated with FEV1 decrease (coefficient = −0.044, 95% CI [−0.085 to −0.004], p = 0.033). Conclusion: AH of outdoor air associates with occurrence and severity of EIB in outdoor exercise tests in children. Care should be taken when interpreting negative outdoor exercise test results if AH of air is high. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Change of pulmonary function tests in hospitalized COVID-19 patients at third and sixth month follow-up.
- Author
-
Kafkas, Meltem Karakulak, Tüzün, Sabah, Hacıağaoğlu, Nazlı, Çetin, Hüseyin, Cömert, Sevda Şener, and Şimşek, Engin Ersin
- Subjects
- *
PULMONARY function tests , *COVID-19 , *DIAGNOSTIC use of polymerase chain reaction , *COVID-19 testing , *LUNG infections - Abstract
Background The effect of COVID-19 infection on pulmonary function is unknown. Objective This study aimed to evaluate pulmonary function tests (PFTs) of patients hospitalized with the diagnosis of COVID-19 pneumonia at 3 and 6 months post-discharge. Methods Patients aged 18 years and over who had positive COVID-19 PCR test results and were hospitalized in the pandemic service between 1 May 2020 and 31 October 2020, were included in the study. All patients were evaluated with PFTs FVC, FEV1, FEV1/FVC, and FEF25–75 at 3 and 6 months after discharge. Results The mean age of 34 patients included in the study was 47.7 ± 12.7 years. The FVC, FEV1, FEV1/FVC, and FEF25–75 measurements at 3 and 6 months post-discharge showed no significant difference (P = 0.765, P = 0.907, P = 0.707, and P = 0.674, respectively). There was no significant difference in any PFT measurements at the third month follow-up, regardless of the pharmacological treatment protocols applied during hospitalization (P > 0.05). However, FEV1/FVC and FEF25–75 levels were 83.1 [3.4]% and 91.0 [10.0]%, respectively, in those who received systemic steroid treatment, and 78.3 ± 8.5% and 72.5 ± 25.7% in those who did not (P = 0.019 and P = 0.048, respectively). In addition, FVC and FEV1 levels increased significantly from the third to the sixth month follow-up in patients who received systemic steroid therapy (P = 0.035 and P = 0.018, respectively). Conclusion Although there is no significant difference in PFT measurements from 3 to 6 months in COVID-19 patients, systemic steroid therapy may have a beneficial effect on respiratory function in COVID-19 patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Assessment of Ventilation Using Adult and Pediatric Manual Resuscitators in a Simulated Adult Patient.
- Author
-
Justice, Joshua M., Slutsky, Arthur S., Stanford, Nathan, Isennock, Christopher, Siddiqui, Sameer, Zamir, Hamza, Walker III, J. Richard, and Brady, Mark F.
- Subjects
ARTIFICIAL respiration equipment ,RESPIRATORY therapy equipment ,CONTINUING education units ,PULMONARY function tests ,RESPIRATORY therapy ,PROFESSIONAL practice ,HUMAN anatomical models ,DATA analysis ,PULMONARY alveoli ,MULTIPLE regression analysis ,QUESTIONNAIRES ,RESPIRATORY insufficiency ,RESUSCITATION ,EMERGENCY medicine ,DESCRIPTIVE statistics ,SIMULATED patients ,MEDICAL masks ,RESPIRATORY measurements ,STATISTICS ,AIRWAY (Anatomy) ,DATA analysis software ,CHILDREN ,ADULTS - Abstract
BACKGROUND: The bag-valve-mask (BVM) or manual resuscitator bag is used as a first-line technique to ventilate patients with respiratory failure. Volume-restricted manual resuscitator bags (eg, pediatric bags) have been suggested to minimize overventilation and associated complications. There are studies that both support and caution against the use of a pediatric resuscitator bag to ventilate an adult patient. In this study, we evaluated the ability of pre-hospital clinicians to adequately ventilate an adult manikin with both an adult- and pediatric-size manual resuscitator bag without the assistance of an advanced airway or airway adjunct device. METHODS: This study was conducted at an international conference in 2022. Conference attendees with pre-hospital health care experience were recruited to ventilate an adult manikin using a BVM for 1 min with both an adult and pediatric resuscitator bag, without the use of adjunct airway devices, while 6 ventilatory variables were collected or calculated: tidal volume (V
T ), breathing frequency, adequate breaths (VT > 150 mL), proportion of adequate breaths, peak inspiratory pressure (PIP), and estimated alveolar ventilation (EAV). RESULTS: A total of 208 participants completed the study. Ventilation with the adult-sized BVM delivered an average VT of 290.4 mL compared to 197.1 mL (P < .001) when using the pediatric BVM. PIP with the adult BVM was higher than with the pediatric BVM (10.6 cm H2 O vs 8.6 cm H2 O, P < .001). The median EAV with the adult bag (1,138.1 [interquartile range [IQR] 194.0-2,869.9] mL/min) was markedly greater than with the pediatric BVM (67.7 [IQR 0-467.3] mL/min, P < .001). CONCLUSIONS: Both pediatric- and adult-sized BVM provided lower ventilation volumes than those recommended by professional guidelines for an adult. Ventilation with the pediatric BVM was significantly worse than with the adult bag when ventilating a simulated adult subject. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
48. Association of Maternal Air Pollution Exposure and Infant Lung Function Is Modified by Genetic Propensity to Oxidative Stress.
- Author
-
Vilcins, Dwan, Lee, Wen Ray, Pham, Cindy, Tanner, Sam, Knibbs, Luke D., Burgner, David, Blake, Tamara L., Mansell, Toby, Ponsonby, Anne-Louise, and Sly, Peter D.
- Subjects
LUNG physiology ,AIR pollution ,PULMONARY function tests ,MATERNAL exposure ,PRENATAL exposure delayed effects ,NITRIC oxide ,SMOKING ,OXIDATIVE stress ,ACUTE phase proteins ,DESCRIPTIVE statistics ,LUNG diseases ,DATA analysis software ,CONFIDENCE intervals ,INFLAMMATION ,C-reactive protein ,BIOMARKERS ,REGRESSION analysis ,SOCIAL classes ,DISEASE risk factors ,CHILDREN ,PREGNANCY - Abstract
Background and objective: The association between air pollution and poor respiratory health outcomes is well established. Children are particularly at risk from air pollution, especially during the prenatal period as their organs and systems are still undergoing crucial development. This study investigated maternal exposure to air pollution during pregnancy and oxidative stress (OS), inflammation, and infant lung function at 4 weeks of age. Methods: Data from the Barwon Infant Study were available for 314 infants. The exposure to NO
2 and PM2.5 were estimated. Infant lung function (4 weeks) was measured by multiple-breath washout. Glycoprotein acetyls (GlycA) (36 weeks prenatal), cord blood, and OS biomarkers were measured in maternal urine (28 weeks). A genetic pathway score for OS (gPFSox) was calculated. Linear regression was used and potential modification by the OS genotype was tested. Results: There was no relationship between maternal exposure to air pollution and infant lung function, or with GlycA or OS during pregnancy. We found an association in children with a genetic propensity to OS between NO2 and a lower functional residual capacity (FRC) (β = −5.3 mls, 95% CI (−9.3, −1.3), p = 0.01) and lung clearance index (LCI) score (β = 0.46 turnovers, (95% CI 0.10, 0.82), p = 0.01). Conclusion: High prenatal exposure to ambient NO2 is associated with a lower FRC and a higher LCI score in infants with a genetic propensity to oxidative stress. There was no relationship between maternal exposure to air pollution with maternal and cord blood inflammation or OS biomarkers. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
49. Use of Lung Ultrasound in Cystic Fibrosis: Is It a Valuable Tool?
- Author
-
Boni, Alessandra, Cristiani, Luca, Majo, Fabio, Ullmann, Nicola, Esposito, Marianna, Supino, Maria Chiara, Tomà, Paolo, Villani, Alberto, Musolino, Anna Maria, and Cutrera, Renato
- Subjects
DISEASE exacerbation ,PLEURAL effusions ,PULMONARY function tests ,BRONCHIECTASIS ,DISEASE management ,COMPUTED tomography ,LUNGS ,ATELECTASIS ,TREATMENT duration ,BRONCHOALVEOLAR lavage ,CYSTIC fibrosis ,SENSITIVITY & specificity (Statistics) ,DISEASE complications - Abstract
Cystic fibrosis (CF) is a multisystem disorder characterized by progressive respiratory deterioration, significantly impacting both quality of life and survival. Over the years, lung ultrasound (LUS) has emerged as a promising tool in pediatric respiratory due to its safety profile and ease at the bedside. In the era of highly effective CF modulator therapies and improved life expectancy, the use of non-ionizing radiation techniques could become an integral part of CF management, particularly in the pediatric population. The present review explores the potential role of LUS in CF management based on available data, analyzing all publications from January 2015 to January 2024, focusing on two key areas: LUS in CF pulmonary exacerbation and its utility in routine clinical management. Nonetheless, LUS exhibits a robust correlation with computed tomography (CT) scans and serves as an additional, user-friendly imaging modality in CF management, demonstrating high specificity and sensitivity in identification, especially in consolidations and atelectasis in the CF population. Due to its ability, LUS could be an instrument to monitor exacerbations with consolidations and to establish therapy duration and monitor atelectasis over time or their evolution after therapeutic bronchoalveolar lavage. On the basis of our analysis, sufficient data emerged showing a good correlation between LUS score and respiratory function tests. Good sensitivity and specificity of the methodology have been found in rare CF pulmonary complications such as effusion and pneumothorax. Regarding its use in follow-up management, the literature reports a moderate correlation between LUS scores and the type, extent, and CT severity score of bronchiectasis. A future validation of ultrasound scores specifically in CF patients could improve the use of LUS to identify pulmonary exacerbations and monitor disease progression. However, further research is needed to comprehensively establish the role of LUS in the CF population, particularly in elucidating its broader utility and long-term impact on patient care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Significance of slow vital capacity, difference between slow and forced vital capacity, ratio of FEV1/SVC with increasing age and BMI in healthy males and females.
- Author
-
Mankar, Komal, Mankar, Tushar, and Dindugala, Ramu
- Subjects
VITAL capacity (Respiration) ,EXPIRATORY flow ,PULMONARY function tests ,AGE groups ,BODY mass index ,RESPIRATORY obstructions - Abstract
Background: The slow vital capacity (SVC), forced vital capacity (FVC) difference, and forced expiratory volume in one second (FEV
1 /SVC ratio are crucial for understanding respiratory health, especially in mild airway obstruction. These parameters are more reliable than traditional measures and are influenced by age and body mass index (BMI). Investigating their relationship can improve diagnostic accuracy and health-care interventions. Aims and Objectives: (i) To record peak expiratory flow rate (PEFR), FVC, FEV1 of expiration, FEV1 /FVC ratio, forced expiratory flow rate (FEF25-75% ), mean forced expiratory flow rate from 0.2 to 1.2 l of volume expired (FEF.2-12 ), SVC, and find the difference between SVC and FVC, ratio of FEV1 /SVC. (ii) To correlate SVC, SVC-FVC, FEV/SVC, and other pulmonary function tests (PFTs) with age, gender, and BMI emphasizing their importance in detecting airway obstruction. (iii) To assess these known indicators of airflow obstruction in healthy individuals to gain knowledge of changing lung health with respect to advancing age, gender, and BMI. Materials and Methods: The study included 200 individuals, comprising both men and women aged between 18 and 60 years, who were in good health. The sample was divided into five age groups, and participants were classified into categories of underweight, normal weight, overweight, and obese based on their BMI. Standard procedures were employed to record anthropometric measurements. PEFR was measured using Wright's peak flow meter, whereas FVC, FEV1 FEV1 /FVC ratio, forced expiratory flow between 25 and 75% of FVC (FEF25-75% ), forced expiratory flow at 2-1.2 l (FEF.2-12), and SVC were assessed using an expirograph (Helios 401, RMS, India). Adequate statistical analysis was conducted on the gathered data. Results: There was a highly significant difference in the means of SVC, SVC-FVC, FEV/SVC, and other PFTs (P < 0.000) over the five age groups by ANOVA and a significant difference between younger and older age groups analyzed by post hoc test. It also showed a highly significant difference in the mean values of SVC, FEV/SVC, and other PFTs over the categories of BMI and a significant difference between normal and obese groups by multiple comparisons. A small increase in mean values of SVC-FVC was seen in overweight, obese, and underweight compared to the normal BMI group. Females showed reduced mean values of SVC, FEV/SVC, and other PFTs compared to males. (P < 0.000). The mean value of SVC-FVC in females is greater than in males (P < 0.01), which suggest that the tendency for airway obstruction may be greater in women compared to men due to smaller airway diameter and diffusion surface. PEFR, FVC, FEV1 FEV1/FVC, FEF25-75% FEF 2-12, SVC, and FEV/SVC were negatively correlated with age. SVC-FVC was positively correlated with age (r = 0.338, P < 0.000). There was a negative correlation between PEFR, FVC, FEV1 , FEF25-75% , FEF.2-12 , SVC, and BMI. Conclusions: PFT serves as a crucial diagnostic tool in assessing respiratory health, with parameters such as FVC and FEV1 commonly utilized. However, SVC is gaining recognition for its nuanced insights into lung function. This article delves into the significance of SVC, highlights the differences between SVC and FVC, and explores the relationship between FEV1 /SVC ratio, age, and BMI in healthy individuals. The current research was undertaken due to a scarcity of existing studies and demonstrated that SVC, the ratio of FEV1 /SVC, and other PFTs diminish with age progression and increasing BMI. In addition, females exhibited decreased lung function, with a greater disparity between SVC and FVC than males. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.